angiotensin ii has been researched along with Atherogenesis in 266 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 95 (35.71) | 29.6817 |
| 2010's | 149 (56.02) | 24.3611 |
| 2020's | 22 (8.27) | 2.80 |
| Authors | Studies |
|---|---|
| Gabandé-Rodríguez, E; Martín-Ventura, JL; Mittelbrunn, M; Oller, J; Redondo, JM; Roldan-Montero, R; Ruiz-Rodríguez, MJ | 1 |
| Bae, E; Han, SW; Kim, JE; Kim, YS; Lee, S; Moon, JJ; Park, DJ; Yang, SH; Yu, MY | 1 |
| Cho, S; Jang, Y; Jeong, J; Lee, BS; Lim, S; Park, S; Seo, M | 1 |
| Azizi, M; Babaahmadi-Rezaei, H; Beheshti-Nasab, H; Ghaderi-Zefrehi, H; Mehta, JL; Rezaei, M | 1 |
| Artigalas, J; Campbell, S; Claing, A; Fiola-Masson, E | 1 |
| Daugherty, A; Hada, Y; Shikata, K; Subramanian, V; Takatsuka, T; Takeuchi, H; Uchida, HA; Umebayashi, R; Wada, J | 1 |
| Alebrahim, D; Attur, M; Byrd, D; Harpel, Z; Lu, C; Maldonado, DJ; Mignatti, P; Pratama, MY; Ramkhelawon, B; Rivera, CF; Silvestro, M; Sleiman Tellaoui, R; Tang, C; Vlahos, J; Zias, AL | 1 |
| Li, W; Song, T; Wu, J; Zhao, M; Zheng, L; Zhou, M | 1 |
| Aono, J; Hamaguchi, M; Ikeda, S; Inoue, K; Kakino, A; Kurata, M; Nakao, Y; Sakaue, T; Sawamura, T; Suehiro, C; Suzuki, J; Takahashi, K; Yamaguchi, O | 1 |
| Deng, M; Mao, Q; Tong, W; Xu, S; Zhao, J; Zhao, X; Zhou, D | 1 |
| Adam, M; Ahdab, M; Baldus, S; Geißen, S; Guthoff, H; Hof, A; Landerer, M; Mehrkens, D; Mollenhauer, M; Niehues, J; Schäkel, J; Schorscher, M; von Stein, P; Winkels, H; Zimmermann, O | 1 |
| Deng, FX; Guo, N; Shu, S; Wang, LJ; Wang, Y; Wu, Y; Yuan, ZY; Zhang, LS; Zhang, Y; Zhou, D; Zhou, J | 1 |
| Das, A; Fukai, T; Sudhahar, V; Ushio-Fukai, M | 1 |
| An, S; Cho, S; Jeong, J; Lee, J; Lee, M; Lim, J; Lim, S; Park, S; Seo, M; Yoon, N | 1 |
| Khoury, MK; Liu, B | 1 |
| Golledge, J; Huynh, P; Jose, RJ; Krishna, SM; Lazzaroni, S; Moran, CS | 1 |
| Deng, CF; Liao, DF; Qin, L; Shi, YN; Wang, W; Xie, XJ; Zhang, YY; Zhu, N | 1 |
| Buitrago, DM; Castillo, DM; Chacon-Quintero, Y; Lafaurie, GI; Morantes, SJ; Viafara-García, SM | 1 |
| Hao, J; Shao, J; Wang, S; Xu, J; Zhang, X; Zhao, L; Zheng, J | 1 |
| Chen, L; FitzGerald, GA; Jiang, T; Monslow, J; Puré, E; Tang, SY; Todd, L; Yang, G; Zhang, J | 1 |
| Autieri, MV; Corbett, CB; Okune, R; St Paul, A | 1 |
| Cassis, LA; Daugherty, A; Howatt, DA; Lu, HS; Moorleghen, JJ; Wu, C; Wu, CH | 1 |
| Chen, H; Chen, L; Hu, P; Li, S; Que, Y; Seta, F; Tong, X; Xiao, L; Xiong, R; Yu, W | 1 |
| Chuma, M; Goda, M; Hosooka, M; Ishizawa, K; Izawa-Ishizawa, Y; Kagimoto, Y; Kondo, M; Matsuoka, R; Saito, N; Takechi, K; Tsuneyama, K; Yagi, K; Zamami, Y | 1 |
| Badran, A; Baydoun, E; Bitto, A; Eid, AH; El-Yazbi, AF; Fardoun, MM; Mesmar, J; Nasser, SA | 1 |
| Cheng, W; Han, J; Liu, J; Wang, Z; Wen, S; Zhou, Q | 1 |
| Ali, H; AlSiraj, Y; Cassis, LA; Ensor, M; Liang, CL; Thatcher, SE | 1 |
| Daugherty, A; Howatt, DA; Kukida, M; Lu, HS; Moorleghen, JJ; Ohno-Urabe, S; Poglitsch, M; Sawada, H | 1 |
| Amato, A; Baldassano, S; Caldara, GF; Di Carlo, M; Mulè, F; Nuzzo, D; Picone, P; Rizzo, M | 1 |
| Berliner, JA; Cai, L; Graham, MJ; Kim, S; Lee, RG; Lee, S; Lusis, AJ; Rateri, DL; Temel, RE; Yang, L | 1 |
| Aureille, J; Baron-Menguy, C; Carbone, ML; Castan, L; Chadeuf, G; Desfrançois, J; Durand, M; Goueffic, Y; Heurtebise-Chrétien, S; Loirand, G; Prieur, X; Quillard, T; Rio, M; Tesse, A; Torres, RM; Vaillant, N | 1 |
| Bansal, A; Chen, Z; Das, S; Ganguly, R; Jia, Y; Lanting, L; Leung, A; Mandi, V; Natarajan, R; Reddy, MA; Schones, DE; Senapati, P; Wu, X; Zhang, S | 1 |
| Blaize, AN; Chang, MS; Ejendal, KFK; Goergen, CJ; Gorman, S; Kinzer-Ursem, TL; Phillips, EH; Qureshi, HJ | 1 |
| Buszman, E; Jasik, K; Rzepecka-Stojko, A; Stojko, J | 1 |
| Al-Omran, M; Plant, PJ; Quan, A; Ramadan, A; Singh, KK; Teoh, H; Verma, S | 1 |
| Lei, H; Li, J; Li, L; Liu, H; Yi, J | 1 |
| Daugherty, A; Kakio, Y; Subramanian, V; Uchida, HA; Umebayashi, R; Wada, J | 1 |
| Antoku, Y; Egashira, K; Honda, K; Ichi, I; Koga, JI; Matoba, T; Nakano, K; Tsutsui, H | 1 |
| Dai, RZ; Gao, F; Li, JS; Zhang, DQ; Zhang, YM | 1 |
| Folestad, E; Länne, T; Rossignoli, A; Skogberg, J; Vorkapic, E; Wågsäter, D; Wanhainen, A | 1 |
| Chen, WQ; Cui, GH; Shen, ZY | 1 |
| Channon, KM; Douglas, G; Hale, AB; Kerr, AG; Patel, J | 1 |
| Cartland, SP; Dang, L; Kavurma, MM; Manuneedhi Cholan, P; Patel, S; Rayner, BS; Thomas, SR | 1 |
| Golledge, J; Kinobe, R; Krishna, SM; Morton, SK; Moxon, JV; Phie, J | 1 |
| Li, K; Liu, JT; Wang, SY; Xu, L; Xu, S | 1 |
| Balakrishnan, A; Danser, AHJ; Daugherty, A; Graham, MJ; Howatt, DA; Lu, HS; Mullick, AE; Wang, J; Wang, Y; Wu, C; Wu, CH; Ye, F | 1 |
| Avery, EG; Balogh, A; Bartolomaeus, H; Dechend, R; Eckardt, KU; Fielitz, J; Forslund, SK; Gollasch, M; Grandoch, M; Haase, N; Hering, L; Höges, S; Homann, S; Kempa, S; Kozhakhmetov, S; Kräker, K; Krannich, A; Kusche-Vihrog, K; Kushugulova, A; Maase, M; Markó, L; Müller, DN; Rump, LC; Stegbauer, J; Tsvetkov, D; Wilck, N; Wundersitz, S; Yakoub, M; Zhumadilov, Z | 1 |
| Fang, C; Lin, L; Moore, A; Wen, G; Wu, S; Xiao, Q; Ye, S; Zhang, L | 1 |
| Cassis, LA; Charnigo, R; Daugherty, A; Howatt, DA; Rateri, DL | 1 |
| Jaffe, IZ; McCurley, A; McGraw, A; Pruthi, D | 1 |
| Fukui, K; Irie, D; Kato, T; Kawahito, H; Kishida, S; Matsubara, H; Miyagawa, S; Takata, H; Wakana, N; Yamada, H | 1 |
| Nelson, C; Tang, T; Tannock, LR; Thompson, JC; Wilson, PG; Yoder, MH | 1 |
| Akakabe, Y; Ikeda, K; Irie, D; Kato, T; Kawahito, H; Kishida, S; Matoba, S; Matsubara, H; Mori, Y; Ogata, T; Takata, H; Ueyama, T; Wakana, N; Yamada, H | 1 |
| Cassis, LA; Chen, X; Daugherty, A; Lu, H; Tashiro, K; Zhao, M | 1 |
| Karunakaran, D; Leenen, FH; Milne, RW; Rafatian, N; Rayner, KJ; Whitman, SC | 1 |
| Cho, S; Chung, JH; Jin, T; Kim, SH; Lee, D; Lee, KH; Lim, S; Park, H; Park, S | 1 |
| Bujak-Gizycka, B; Gebska, A; Jawien, J; Korbut, R; Kus, K; Madej, J; Olszanecki, R; Suski, M; Toton-Zuranska, J | 1 |
| Fujimoto, K; Itoh, F; Koyama, T; Noguchi, Y; Sato, K; Shichiri, M; Watanabe, T | 1 |
| Chen, YQ; Gao, YG; Gong, CS; Liu, WL; Wu, XD; Zeng, K; Zhang, CX | 1 |
| Hitomi, H; Iwamoto, T; Kobori, H; Liu, G; Ma, H; Masaki, T; Mori, H; Nakano, D; Nishiyama, A; Rahman, A | 1 |
| Hazama, A; Katsuda, S; Kojima, I; Miyashita, H; Miyawaki, Y; Shimada, K; Shiogai, Y | 1 |
| Clasen, T; Fähling, M; Ishak, B; Kojda, G; Mende, S; Patzak, A; Potthoff, SA; Rump, LC; Sivritas, SH; Stamer, S; Stegbauer, J; Suvorava, T; Thieme, M | 1 |
| Hirata, Y; Ikutomi, M; Minami, Y; Morita, T; Nagai, R; Nakajima, T; Sahara, M; Sata, M | 1 |
| Balakrishnan, A; Cassis, LA; Charnigo, R; Chen, X; Daugherty, A; Howatt, DA; Moorleghen, JJ; Morris, AJ; Rateri, DL | 1 |
| Guan, L; Guan, Y; Li, M; Liu, J; Zhai, F; Zhang, X | 1 |
| Cai, S; Chu, X; Li, Y; Liu, X; Sun, T; Wang, Q; Xu, Q; Zhou, J | 1 |
| Jiang, L; Lakatta, EG; Monticone, RE; Wang, M | 1 |
| Airey, D; F Linton, M; Fazio, S; Hill, MF; Kon, V; Nwosu, S; Perati, PR; Prins, PA; Sampson, UK; Tavori, H | 1 |
| Barish, GD; Kim, J; Tangirala, RK; Tietge, UJ; van Stijn, CM | 1 |
| Golledge, J; Krishna, SM; Liu, D; Moran, CS; Seto, SW | 1 |
| Montezano, AC; Nguyen Dinh Cat, A; Rios, FJ; Touyz, RM | 1 |
| Choi, E; Ham, O; Hwang, KC; Kim, MH; Lee, CY; Lee, J; Lee, SY; Min, PK; Park, JH; Seo, HH; Seung, M | 1 |
| Fiedler, R; Girndt, M; Seibert, E; Trojanowicz, B; Ulrich, C | 1 |
| Fischer, JW; Müeller, J; Tang, T; Tannock, LR; Thompson, JC; Williams, KJ; Wilson, PG; Yoder, MH | 1 |
| Lakatta, EG; Monticone, RE; Wang, M | 2 |
| Cheng, XW; Hamrah, MS; Hao, CN; Hayashi, M; Hu, L; Kuzuya, M; Murohara, T; Shi, GP; Takeshita, K; Wu, H | 1 |
| Biros, E; Clancy, P; Golledge, J; Jose, RJ; Krishna, SM; Moran, CS; Seto, SW; Wang, Y | 1 |
| Chai, M; Dong, Z; Ji, Q; Lin, Y; Liu, Y; Lu, Q; Meng, K; Wu, B; Yu, K; Zeng, Q; Zhang, J; Zhou, Y | 1 |
| Balakrishnan, A; Cassis, LA; Daugherty, A; Howatt, DA; Lu, H; Moorleghen, JJ; Vander Kooi, CW; Wang, JA; Wu, C; Xu, Y | 1 |
| Chen, X; Dong, B; Dong, XF; Hao, QQ; Li, SY; Tengbeh, AF; Yu, QT; Zhang, Y; Zhang, YH; Zhou, XM | 1 |
| Bian, YF; Gao, F; Liang, B; Xiao, CS; Yang, HY; Yang, ZM; Zhang, N | 1 |
| Chelakkot-Govindalayathil, AL; D'Alessandro-Gabazza, CN; Gabazza, EC; Harada, E; Morizono, T; Roeen, Z; Sumiya, T; Toda, M; Urawa, M; Yano, Y; Yasuma, T | 1 |
| Chlopicki, S; Kij, A; Olkowicz, M; Radulska, A; Smolenski, RT; Suraj, J; Walczak, M | 1 |
| Beneit, N; Benito, M; Díaz-Castroverde, S; Escribano, Ó; Gómez-Hernández, A; Otero, YF; Perdomo, L | 1 |
| Balakrishnan, A; Cassis, LA; Daugherty, A; Howatt, DA; Moorleghen, JJ; Poduri, A; Rateri, DL | 1 |
| Fan, F; Li, S; Nie, W; Yan, H; Zhu, J; Zhu, W | 1 |
| Ait-Oufella, H; Mallat, Z; Potteaux, S | 1 |
| Cai, Y; Chen, YX; Dai, W; Zhang, M; Zhao, Q | 1 |
| Bragina, ME; Caffa, I; Costa-Fraga, FP; da Silva, RF; Fraga-Silva, RA; Mach, F; Montecucco, F; Nencioni, A; Raizada, MK; Santos, RAS; Stergiopulos, N | 1 |
| Amstutz, C; Aubert, JF; Bouzourène, K; Mazzolai, L; Pellegrin, M | 1 |
| Balakrishnan, A; Cassis, LA; Chen, X; Crooke, RM; Daugherty, A; Feldman, DL; Graham, MJ; Howatt, DA; Lu, H; Moorleghen, JJ; Mullick, AE; Vander Kooi, CW; Wu, C; Zhao, M | 1 |
| Koltsova, EK; Peshkova, IO; Schaefer, G | 1 |
| Chen, X; Deng, Y; Ding, D; Hu, X; Liao, Y; Pan, Y; Qiu, Z; Song, X; Wang, M; Wang, S; Wu, H; Yang, S; Zhang, H; Zhou, Y; Zhou, Z | 1 |
| Egashira, K; Katsuki, S; Koga, J; Matoba, T; Nakano, K; Nakashiro, S; Sunagawa, K; Tokutome, M; Umezu, R | 1 |
| Chen, J; Cui, G; Diao, H; Ding, Y; Lu, C; Wang, L; Wei, Y | 1 |
| Pantan, R; Suksamrarn, A; Tocharus, C; Tocharus, J | 1 |
| Balakrishnan, A; Baud, L; Chishti, AH; Howatt, DA; Moorleghen, JJ; Muniappan, L; Rateri, DL; Saido, TC; Subramanian, V; Takano, J; Uchida, HA | 1 |
| Ganji, SK; Gopoju, R; Kanugula, AK; Karnewar, S; Kotamraju, S; Kumar, JM; Prabhakar, S; Rangaraj, N; Tupperwar, N; Vasamsetti, SB | 1 |
| Baldi, S; Balzan, S; Lubrano, V; Natali, A; Venturi, E | 1 |
| Çetin, A; Kırça, M; Oğuz, N; Uzuner, F; Yeşilkaya, A | 1 |
| Chen, W; Hao, P; Li, H; Li, J; Li, W; Meng, X; Yang, J; Zhang, C; Zhang, Y | 1 |
| De Meyer, GR; Martinet, W; Roth, L; Schrijvers, DM | 1 |
| Chen, XQ; Duan, SZ; Li, C; Liu, X; Shen, ZX; Shi, HJ; Sun, JY; Sun, XN; Wang, J; Zhang, JW; Zhang, WC; Zhang, YY; Zheng, XJ | 1 |
| Nešić, IM; Prostran, M; Radenkovic, M; Stojanović, M | 1 |
| Towler, DA | 1 |
| Chen, H; Cui, Y; Li, S; Liu, J; Song, J; Zhang, F | 1 |
| Qin, Z | 1 |
| Sullivan, JL | 1 |
| Al-Omran, M; Backx, PH; Levitt, KS; Lovren, F; Oudit, GY; Pan, Y; Penninger, JM; Peterson, MD; Quan, A; Shukla, PC; Slutsky, AS; Stewart, DJ; Teoh, H; Verma, S; Wang, G | 1 |
| Agrawal, R; Ali, ZA; Anderson, JP; Ashley, EA; Chun, HJ; Kojima, Y; Kundu, RK; Leeper, NJ; Lenardo, MJ; Patterson, AJ; Pearl, NE; Quertermous, T; Sheikh, AY; Tsao, PS; Zheng, L | 1 |
| Davis, BB; Fiehn, O; Hammock, BD; Inceoglu, B; Kim, IH; Morisseau, C; Tsai, HJ; Ulu, A; Weiss, RH | 1 |
| Egashira, K; Horiuchi, M; Ihara, Y; Iwai, M; Koga, J; Kubo, M; Matoba, T; Sunagawa, K | 1 |
| Hongo, S; Kanome, T; Miyazaki, A; Nishio, K; Takahashi, K; Watanabe, T | 1 |
| Lakatta, EG; Wang, M | 1 |
| Major, TC; Olszewski, B; Rosebury-Smith, WS | 1 |
| Liu, JG; Xu, FQ; Xu, H | 1 |
| Andersson, IJ; Bergström, G; Bernberg, E; Bie, P; Gan, LM; Johansson, ME; Skøtt, O | 1 |
| Hao, H; Jiang, YJ; Wang, YY; Xue, S; Yin, BL | 1 |
| Aihara, K; Akaike, M; Azuma, H; Ikeda, Y; Ise, T; Ishikawa, K; Iwase, T; Kato, S; Matsumoto, T; Sato, T; Sumitomo, Y; Yagi, S; Yoshida, S | 1 |
| Cassis, LA; Charnigo, R; Daugherty, A; Gupte, M; Howatt, DA; Rateri, DL; Thayer, S; Zhang, X | 1 |
| Ide, N; Node, K | 1 |
| Fukuda, D; Hirata, Y; Sata, M | 2 |
| Cheng, J; Crumpacker, CS; Jin, Z; Ke, Q; Kocher, O; Morgan, JP; Wang, H; Zhang, J | 1 |
| Cole, RN; Everett, AD; Fu, Z; Gucek, M; Ingram, DK; Jiang, L; Khazan, B; Kolodgie, FD; Lakatta, EG; Liu, L; Mattison, J; Monticone, RE; Pintus, G; Sheng, S; Spinetti, G; Spurgeon, H; Telljohann, R; Van Eyk, JE; Virmani, R; Wang, M; Wu, J; Zhang, J | 1 |
| Chen, WQ; Guo, T; Zhang, C; Zhang, Y; Zhao, YX | 1 |
| de Winther, MP; Gijbels, MJ; Lutgens, E; Pöttgens, C; Thelen, M; Xanthoulea, S | 1 |
| Bader, M; Fonseca, RG; Merino, VF; Mori, MA; Pesquero, JB; Sales, VM; Saul, V; Tenner, K; Todiras, M | 1 |
| Ashihara, E; Hirai, H; Imanishi, J; Kawahito, H; Kishida, S; Maekawa, T; Matsubara, H; Matsui, A; Nozawa, Y; Okigaki, M; Takahashi, T; Takata, H; Tsubakimoto, Y; Urao, N; Yamada, H; Yokoi, H | 1 |
| Anandan, SK; Chen, D; Cheng, Y; Gless, R; Mehra, U; Vincelette, J; Wang, YX; Webb, HK; Zhang, LN | 1 |
| Aizawa, Y; Azuma, J; Doi, T; Iekushi, K; Koibuchi, N; Kusunoki, H; Morishita, R; Okayama, K; Sanada, F; Taniyama, Y | 1 |
| Ahluwalia, A; Duchene, J; Hodgkinson, CP; Hu, Y; Kiechl, S; Laxton, RC; Leung, KY; López-Otín, C; Scotland, RS; Simpson, IA; Smith, K; Willeit, J; Xiao, Q; Xu, Q; Ye, S; Zhang, F; Zhang, Z | 1 |
| de Crom, R; Lehoux, S; Mees, B; Ramkhelawon, B; Rivas, D; Tedgui, A; Vilar, J | 1 |
| Drummond, GR; Harrison, CB; Selemidis, S; Sobey, CG | 1 |
| Mallat, Z | 1 |
| Apostolakis, S; Krambovitis, E; Spandidos, DA; Vlata, Z; Vogiatzi, K | 1 |
| Bunker, AK; Laughlin, MH | 1 |
| Aravindhan, K; Bernard, RE; Cornejo, CA; Goodman, KB; Gough, PJ; Hoang, B; Jucker, BM; Karr, H; Macphee, CH; Olzinski, AR; Qin, P; Ringenberg, MA; Sehon, CA; Turner, GH; Willette, RN | 1 |
| Blinder, Y; Guzik, TJ; Harrison, DG; Iwakura, Y; Lob, HE; Madhur, MS; McCann, LA | 1 |
| Aizawa, T; Fujiu, K; Hara, K; Horikoshi, M; Imai, Y; Kadowaki, T; Manabe, I; Nagai, R; Oishi, Y; Tanaka, T | 1 |
| Fukuda, D; Sata, M | 3 |
| Cassis, LA; Charnigo, R; Daugherty, A; Kristo, F; Lu, H; Rateri, DL; Uchida, HA | 1 |
| Rizvi, AA | 1 |
| Casley, D; Gaspari, TA; Tesanovic, S; Vinh, A; Widdop, RE | 1 |
| Libby, P; Lopez-Ilasaca, M; Macfarlane, L; Schulte, S; Shi, GP; Sukhova, GK; Sun, C; Sun, J | 1 |
| Fu, H; Guo, Y; Huang, H; Liu, X; Luo, F; Pan, P; Wu, W; Zhang, L | 1 |
| An, J; Kimura, A; Kuba, K; Nakajima, T | 1 |
| Isosaki, M; Kyotani, Y; Nakayama, H; Tomita, S; Uno, M; Yoshizumi, M; Zhao, J | 1 |
| Han, C; Li, M; Liu, J; Liu, X | 1 |
| Ceconi, C; Ferrari, R; Guardigli, G | 1 |
| Delekta, PC; Gu, S; Jin, X; Lucas, PC; McAllister-Lucas, LM; McDonnell, S; Ruland, J; Siu, K; Van Beek, M | 1 |
| Jin, D; Miyazaki, M; Takai, S | 1 |
| Hayashi, N; Iwamoto, Y; Oguro, R; Ohishi, M; Rakugi, H; Shiota, A; Takeda, M; Takeya, Y; Tatara, Y; Yamamoto, K | 1 |
| Bruemmer, D; Daugherty, A; Golledge, J; Ijaz, T; Subramanian, V | 1 |
| Chung, IM; Kim, CK; Kim, YM; Shin, MK; Suh, SH; Yoo, MH | 1 |
| Aoyama, T; Minatoguchi, S | 1 |
| Hayashi, S; Hazama, A; Katsuda, S; Kusanagi, M; Murakawa, M; Obara, S | 1 |
| Cassis, LA; Daugherty, A; Gurley, SB; Howatt, DA; Lu, H; Thatcher, SE; Zhang, X | 1 |
| Li, Y; Liu, N; Ren, L; Sheng, Z; Tang, R; Zhi, H | 1 |
| Huang, Y; Ji, QW; Liu, XH; Zeng, QT | 1 |
| Chen, S; Guo, Z; Huang, X; Lin, L; Liu, J; Liu, X; Qin, Y; Wang, Y; Yuan, W; Zhang, D; Zhu, N | 1 |
| Au, CL; Gollasch, M; Huang, Y; Lau, CW; Ng, CF; Ng, SS; Wong, SL; Wong, WT; Xu, A; Yao, X | 1 |
| Clasen, T; Friedrich, S; Königshausen, E; Mergia, E; Potthoff, SA; Quack, I; Rump, LC; Sellin, L; Stegbauer, J; Vonend, O; Woznowski, M | 1 |
| Blinder, Y; Chen, W; Funt, SA; Harrison, DG; Iwakura, Y; Li, L; Lob, HE; Madhur, MS; Quyyumi, AA; Rahman, A; Vinh, A | 1 |
| Bi, H; Chen, WA; Daugherty, A; Hong, B; Luo, Y; Wang, JA; Wang, Y; Xie, X; Zhang, S | 1 |
| Coşkun Yilmaz, B; Kaplan, HM; Karaca, MK; Ozeren, M; Singirik, E; Sucu, N; Vezir, O; Yaktubay Döndaş, N | 1 |
| Courtman, DW; Rampersad, SN; Stewart, DJ; Suen, RS | 1 |
| Deshmukh, A; Lu, J; Mehta, JL; Mitra, S; Sachdeva, R | 1 |
| Bortz, PD; Halterman, JA; Kwon, HM; Wamhoff, BR; Zargham, R | 1 |
| Bi, H; Daugherty, A; Wang, JA; Wang, Y; Xie, X; Xu, Y; Zhang, G; Zhang, S | 1 |
| Dikalov, S | 1 |
| Arsenescu, R; Arsenescu, V; Baker, N; Cassis, LA; Karounos, M; Parulkar, M; Zhang, X | 1 |
| Cassis, LA; Curtiss, LK; Daugherty, A; Howatt, DA; Lu, H; Moore, KJ; Owens, AP; Rateri, DL; Tobias, PS | 1 |
| Balakrishnan, A; Howatt, DA; Ijaz, T; Moorleghen, JJ; Subramanian, V; Uchida, HA | 1 |
| Fazio, S; Fogo, AB; Ichikawa, I; Kaseda, R; Kon, V; Linton, MF; Ma, LJ; Yamamoto, S; Yancey, PG; Zuo, Y | 1 |
| Balakrishnan, A; Cassis, LA; Charnigo, R; Daugherty, A; Howatt, DA; Liau, G; Lu, H; Wu, C | 1 |
| Sata, M | 1 |
| Cassis, LA; Charnigo, R; Daugherty, A; Howatt, DA; Lu, H; Moorleghen, JJ; Subramanian, V; Wang, S | 1 |
| Bendall, JK; Carter, EE; Channon, KM; Crabtree, MJ; Douglas, G; Hale, AB; Tatham, AL | 1 |
| Caligiuri, G; Clement, M; Fornasa, G; Gaston, AT; Groyer, E; Guedj, K; Kaveri, SV; Khallou-Laschet, J; Michel, JB; Morvan, M; Nicoletti, A; Tedgui, A | 1 |
| Liu, L; Shi, GP | 1 |
| Chen, T; Du, C; Fan, F; Li, S; Nie, W; Yan, H; Yang, L; Zhu, J; Zhu, W | 1 |
| Aono, J; Higaki, J; Horiuchi, M; Inoue, K; Iwai, M; Nagai, T; Nishimura, K; Ogimoto, A; Okayama, H; Suzuki, J | 1 |
| Bruemmer, D; Cassis, LA; Charnigo, R; Daugherty, A; Rateri, DL; Thatcher, SE; Zhang, X | 1 |
| Brown, PM; Cao, RY; Funk, CD; Li, X; Maruyama, T; Song, H; St Amand, T; Wang, CP; Yoon, SH; Zelt, DT | 1 |
| Arita, Y; Fujio, Y; Hashimoto, T; Higuchi, K; Ikeoka, K; Komuro, I; Kuroda, T; Minami, T; Mochizuki, N; Nakaoka, Y; Nishida, K; Shioyama, W; Shirai, M; Yamauchi-Takihara, K; Yasui, T | 1 |
| Brummer, T; Halbach, S; Wöhrle, FU | 1 |
| Antonioli, L; Aydinoglu, F; Bernardini, N; Blandizzi, C; Colucci, R; Duranti, E; Fornai, M; Ippolito, C; Rugani, I; Segnani, C; Taddei, S; Virdis, A | 1 |
| Csiszar, K; Fong, SF; Joseph, G; O'Donnell, RE; Rafferty, K; Remus, EW; Taylor, WR; Weiss, D | 1 |
| Fukui, K; Matsubara, H; Yamada, H | 1 |
| Albertos, F; Blanes, JI; Company, C; González-Navarro, H; López-Ginés, C; Ludwig, A; Morcillo, EJ; Piqueras, L; Rius, C; Sanz, MJ | 1 |
| Balakrishnan, A; Cassis, LA; Daugherty, A; Howatt, DA; Moorleghen, JJ; Owens, AP; Poduri, A | 1 |
| Fang, H; Li, D; Li, M; Lin, J; Mohabeer, N; Su, Y; Wang, L; Zhao, H | 1 |
| Miura, S; Saku, K; Uehara, Y; Yahiro, E | 1 |
| Fujisaka, T; Hanafusa, T; Hoshiga, M; Hotchi, J; Ishizaka, N; Jin, D; Takai, S; Takeda, Y | 1 |
| Campbell, IC; Oshinski, JN; Suever, JD; Taylor, WR; Veneziani, A; Virmani, R; Vito, RP; Weiss, D | 1 |
| Chan, K; Chen, H; Ren, J; Zhang, F | 1 |
| Mehta, JL | 1 |
| Ayabe, N; Babaev, VR; Fazio, S; Fogo, AB; Ichikawa, I; Kon, V; Linton, MF; Tang, Y; Tanizawa, T | 1 |
| Chen, R; Horiuchi, M; Ide, A; Iwai, M; Li, Z; Min, LJ; Mogi, M; Okumura, M; Shiuchi, T; Suzuki, J; Tsuda, M | 1 |
| Babamusta, F; Daugherty, A; Howatt, DA; Li, XA; Moorleghen, JJ; Rateri, DL | 1 |
| Chen, J; Hermonat, PL; Liu, H; Liu, Y; Mehta, JL | 1 |
| Niemiec, P; Zak, I | 1 |
| Blaschke, F; Bruemmer, D; Caglayan, E; Chu, V; Collins, AR; Daley, W; Fishbein, MC; Higaki, J; Hsueh, WA; Law, RE; Lyon, CJ; Takata, Y; Tangirala, RK; Wang, W | 1 |
| Packer, CS | 1 |
| Hernandez Schulman, I; Jaimes, EA; Pagano, PJ; Raij, L; Zhou, MS | 1 |
| Bauersachs, J; Thum, T | 1 |
| Cipollone, F; Fazia, ML; Mezzetti, A | 1 |
| Nickenig, G; Wassmann, S | 1 |
| Raij, L; Schulman, IH; Zhou, MS | 1 |
| Raij, L; Schulman, IH; Zachariah, M | 1 |
| Fuster, V; Levy, AP; Moreno, PR; Purushothaman, KR; Sirol, M | 1 |
| Cheng, C; Daemen, MJ; de Crom, R; Grosveld, F; Krams, R; Tempel, D; van der Baan, A; van Haperen, R | 1 |
| Ushio-Fukai, M | 1 |
| Ferrario, CM; Strawn, WB | 1 |
| Cassis, LA; Daugherty, A; Dellsperger, KC; Gavrila, D; McCormick, ML; Miller, FJ; Thomas, M; Weintraub, NL | 1 |
| Choy, DF; da Cunha, V; Halks-Miller, M; Li, WW; Mahmoudi, M; Martin-McNulty, B; Schroeder, M; Sullivan, ME; Vergona, R; Vincelette, J; Wang, YX; Wilson, DW | 1 |
| Kaneko, S; Katsuno, T; Komuro, I; Kunieda, T; Minamino, T; Miyauchi, H; Nagai, T; Nishi, J; Okada, S; Orimo, M; Oyama, T; Takamura, M; Tateno, K | 1 |
| Macdonald, GJ | 1 |
| Böhm, M; Clever, YP; Friedrich, EB; Nickenig, G; Wassmann, S; Werner, N | 1 |
| Kaakinen, R; Kovanen, PT; Lindstedt, KA; Oörni, K; Sneck, M | 1 |
| Chrousos, GP; Magiakou, MA; Smyrnaki, P | 1 |
| Fujita, K; Funahashi, T; Hibuse, T; Hiuge, A; Kihara, S; Kumada, M; Kurata, A; Kuriyama, H; Maeda, N; Nishizawa, H; Ohashi, K; Okada, T; Shimomura, I; Sonoda, M; Yasui, A | 1 |
| Catravas, JD; Chatterjee, A; Dimitropoulou, C; McCloud, L; Yetik-Anacak, G | 1 |
| Gao, DF; Li, R; Lin, R; Liu, JT; Peng, N | 1 |
| Harris, S; Naina, HV | 1 |
| Boldogh, I; Brasier, AR; Hou, T; Lee, CY; LeJeune, WS; Lu, M; Recinos, A; Sun, H; Tieu, BC; Tilton, RG | 1 |
| Chiarelli, F; Di Marzio, D; Giannini, C; Mohn, A; Mokini, ZH | 1 |
| Cassis, LA; Daugherty, A; Lu, H; Rateri, DL | 1 |
| Bae, SS; Heo, HJ; Jung, KH; Kim, CD; Lee, JY; Lee, SJ; Lee, WS; Park, JY; Yun, MR | 1 |
| Komuro, I; Minamino, T | 1 |
| Chaqour, B; Chung, JW; Kim, HS; Kim, JY; Koo, BK; Lee, HY; Oh, BH; Park, KW; Park, YB; Walsh, K; Youn, SW | 1 |
| Kamezaki, F; Koide, S; Nakashima, Y; Okazaki, M; Otsuji, Y; Ozumi, K; Sasaguri, Y; Takatsu, H; Tamura, M; Tanimoto, A; Tasaki, H | 1 |
| Goettsch, C; Morawietz, H; Muller, G | 1 |
| Bennett, MR; Littlewood, TD | 1 |
| Fava, C; Lechi, A; Minuz, P | 1 |
| Browatzki, M; Kranzhöfer, R; Pfeiffer, CA; Ruef, J; Schmidt, J | 1 |
| Croze, E; Fitch, RM; Sullivan, ME; Velichko, S; Vergona, R; Vincelette, J; Wang, YX; Zhang, LN | 1 |
| Lu, J; Qu, ZL; Ren, XY; Ruan, QR; Zhu, DH; Zhu, M | 1 |
| Dechend, R; Dietz, R; Gross, V; Henke, N; Luft, FC; Muller, DN; Obst, M; Park, JK; Qadri, F; Scheidereit, C; Schmidt-Ullrich, R; Wellner, M | 1 |
| Ayabe, N; Babaev, VR; Fazio, S; Fogo, AB; Ichikawa, I; Kon, V; Linton, MF; Motojima, M; Suganuma, E; Zuo, Y | 1 |
| Guzik, TJ; Harrison, DG | 1 |
| Matsubara, H | 1 |
| Abu Nabah, YN; Company, C; Cortijo, J; Estellés, R; Jose, PJ; Lopez-Gines, C; Losada, M; Mateo, T; Morcillo, EJ; Piqueras, L; Sanz, MJ; Sarau, H | 1 |
| Boyle, PJ | 1 |
| Bak, S; Coleman, T; Osher, E; Semenkovich, CF; Stern, N; Tordjman, KM; Vechoropoulos, M; Yudovich, R | 1 |
| Fukuda, D; Ishizaka, N; Nagai, R; Sata, M | 1 |
| Deng, GG; Dole, WP; Gu, JM; Halks-Miller, M; Kauser, K; Liu, P; Qian, HS; Sullivan, ME; Vergona, R | 1 |
| Aung, HH; Huang, F; Rutledge, JC; Tannock, LR; Thompson, JC; Wilson, PG | 1 |
| Cassis, LA; Daugherty, A; King, VL | 1 |
| Chaikof, EL; Haller, CA; Wang, P; Wang, W; Wen, J | 1 |
| Mueller, CF; Nickenig, G | 1 |
| Taylor, WR; Weiss, D | 1 |
| Aravindhan, K; Bernard, RE; Boyce, R; Jucker, BM; Mirabile, RC; Morris, JB; Olzinski, AR; Willette, RN | 1 |
| Barton, M; Bhattacharya, I; Kretz, M; Mundy, AL; Widmer, CC | 1 |
| Katoh, C; Kumagai, A; Magota, K; Morimoto, T; Murakami, R; Okumura, K; Osanai, T; Tanaka, M; Tomita, H | 1 |
| Brooks, LG; D'Angola, A; Gonzales, JA; McCabe, PM; Mendez, AJ; Nation, DA; Paredes, J; Schneiderman, N; Szeto, A; Zaias, J | 1 |
| Badimon, L; Costales, P; Huesca-Gómez, C; Llorente-Cortés, V; Sendra, J | 1 |
| Chai, SY; Gaspari, TA; Vinh, A; Widdop, RE | 1 |
| Atkins, AR; Barish, GD; Collins, AR; Downes, M; Evans, RM; Hsueh, WA; Lee, CH; Liu, J; Lyon, CJ; Takata, Y; Tangirala, RK; Yin, F | 1 |
| Deng, BP; Dong, B; Dong, QL; Feng, JB; Li, SY; Liu, B; Liu, CX; Pan, CM; Song, HD; Yang, YP; Yu, QT; Zhang, C; Zhang, MX; Zhang, Y; Zhao, YX; Zhu, L | 1 |
| Ichiki, T; Imayama, I; Inanaga, K; Miyazaki, R; Ohtsubo, H; Patton, D; Sunagawa, K; Tian, Q; Yano, K | 1 |
| Cassis, LA; Daugherty, A; Henriques, T; Yiannikouris, FB; Zhang, X | 1 |
46 review(s) available for angiotensin ii and Atherogenesis
| Article | Year |
|---|---|
Autophagy: a killer or guardian of vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Atherosclerosis; Autophagy; Cell Proliferation; Humans; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Signal Transduction | 2020 |
Angiotensin II, Hypercholesterolemia, and Vascular Smooth Muscle Cells: A Perfect Trio for Vascular Pathology.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Atherosclerosis; Blood Pressure; Cardiovascular Diseases; Cells, Cultured; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Signal Transduction | 2020 |
Reactive Oxygen Species: Modulators of Phenotypic Switch of Vascular Smooth Muscle Cells.
Topics: Angiotensin II; Antioxidants; Atherosclerosis; Biomarkers; Cardiovascular Agents; Cell Cycle Proteins; Cell Movement; Cell Proliferation; Fibroblast Growth Factors; Gene Expression Regulation; Graft Occlusion, Vascular; Humans; Hypertension; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Oxidative Stress; Phenotype; Reactive Oxygen Species; Signal Transduction | 2020 |
Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease.
Topics: Aging; Aldosterone; Angiotensin II; Animals; Atherosclerosis; Blood Pressure; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Carotid Arteries; Fibrosis; Gene Expression Regulation; Humans; Hypertension; Mice; Muscle, Smooth, Vascular; Placenta Growth Factor; Pregnancy Proteins; Receptors, Mineralocorticoid; Signal Transduction | 2013 |
Emerging roles for vasoactive peptides in diagnostic and therapeutic strategies against atherosclerotic cardiovascular diseases.
Topics: Adiponectin; Angiotensin II; Animals; Atherosclerosis; Biomarkers; Glucagon-Like Peptide 1; Humans; Intercellular Signaling Peptides and Proteins; Molecular Targeted Therapy; Neuregulin-1; Serotonin; Urotensins | 2013 |
Proinflammation: the key to arterial aging.
Topics: Aged; Aging; Angiotensin II; Animals; Antigens, Surface; Arteries; Arteritis; Atherosclerosis; Calpain; Chemokine CCL2; Endothelin-1; Humans; Hypertension; Inflammation; Inflammation Mediators; Matrix Metalloproteinase 2; Middle Aged; Milk Proteins; Muscle, Smooth, Vascular; Nitric Oxide; Reactive Oxygen Species; Receptors, CCR2; Transforming Growth Factor beta1 | 2014 |
Angiotensin II and vascular injury.
Topics: Angiotensin II; Animals; Atherosclerosis; Cardiovascular Diseases; Humans; Hypertension; Muscle, Smooth, Vascular; Oxidation-Reduction; Reactive Oxygen Species; Renin-Angiotensin System; Signal Transduction; Vascular Remodeling; Vascular System Injuries | 2014 |
Proinflammation of aging central arteries: a mini-review.
Topics: Aging; Angiotensin II; Animals; Arteries; Atherosclerosis; Haplorhini; Humans; Hypertension; Myocytes, Smooth Muscle; Rabbits; Rats; Signal Transduction; Tunica Intima; Tunica Media; Vascular Remodeling | 2014 |
Role of splenic monocytes in atherosclerosis.
Topics: Angiotensin II; Animals; Atherosclerosis; Humans; Monocytes; Plaque, Atherosclerotic; Spleen | 2015 |
Atherosclerosis and aortic aneurysm - is inflammation a common denominator?
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Atherosclerosis; Cytokines; Diet, Western; Disease Models, Animal; Gene Expression Regulation; Humans; Inflammation; Risk Factors; Sedentary Behavior; Smoking | 2016 |
Pathophysiological role of osteopontin and angiotensin II in atherosclerosis.
Topics: Angiotensin II; Animals; Atherosclerosis; Humans; Immunologic Factors; Models, Cardiovascular; Models, Immunological; Osteopontin; Vasculitis | 2016 |
Angiotensin receptor blockers & endothelial dysfunction: Possible correlation & therapeutic implications.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Endothelium, Vascular; Humans; Nitric Oxide | 2016 |
Newly developed angiotensin II-infused experimental models in vascular biology.
Topics: Angiotensin II; Animals; Atherosclerosis; Blood Pressure; Blood Vessels; Female; Humans; Hypertension; Inflammation; Mice; Mice, Transgenic; Models, Biological; Neovascularization, Pathologic; Neovascularization, Physiologic; Postmenopause; Pre-Eclampsia; Pregnancy; Vascular Diseases | 2008 |
Iron in arterial plaque: modifiable risk factor for atherosclerosis.
Topics: Angiotensin II; Animals; Antimicrobial Cationic Peptides; Atherosclerosis; Carotid Arteries; Ferritins; Haptoglobins; Heme Oxygenase-1; Hemochromatosis; Hepcidins; Humans; Inflammation; Interleukin-6; Iron; Macrophages; Polymorphism, Genetic; Risk Factors | 2009 |
[Vascular endothelial dysfunction].
Topics: Angiotensin II; Animals; Atherosclerosis; Blood Vessels; Endothelial Cells; Humans; Renin-Angiotensin System | 2009 |
[The role of renin-angiotensin system in the pathogenesis of atherosclerosis].
Topics: Angiotensin II; Animals; Atherosclerosis; Humans; Reactive Oxygen Species; Renin-Angiotensin System | 2009 |
Arterial aging: a journey into subclinical arterial disease.
Topics: Aging; Angiotensin II; Animals; Arteries; Atherosclerosis; Humans; Signal Transduction; Vascular Diseases | 2010 |
Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis.
Topics: Angiotensin II; Atherosclerosis; Bone Marrow; Humans; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 2010 |
Secondary prevention of CAD with ACE inhibitors: a struggle between life and death of the endothelium.
Topics: Acute Coronary Syndrome; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Apoptosis; Atherosclerosis; Bradykinin; Cardiotonic Agents; Coronary Artery Disease; Disease Progression; Endothelial Cells; Endothelium, Vascular; Heart Failure; Humans; Hypertension; Peptidyl-Dipeptidase A; Perindopril; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic; Secondary Prevention; Stem Cells | 2010 |
Chymase as an important target for preventing complications of metabolic syndrome.
Topics: Angiotensin II; Animals; Atherosclerosis; Chymases; Diabetes Complications; Diabetic Retinopathy; Fatty Liver; Humans; Hypertension; Matrix Metalloproteinase 9; Metabolic Syndrome; Mice; Transforming Growth Factor beta | 2010 |
[Critical role of renin-angiotensin system in the pathogenesis of atherosclerosis].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atherosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Disease Progression; Endothelium, Vascular; Humans; Inflammation; Reactive Oxygen Species; Renin-Angiotensin System | 2011 |
[The effect of ARB on prevention of atherosclerosis].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Humans; Inflammation; Myocardial Infarction; Oxidative Stress; Randomized Controlled Trials as Topic; Risk Factors; Stroke | 2011 |
Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy.
Topics: Angiotensin II; Animals; Antioxidants; Apoptosis; Atherosclerosis; Endothelium, Vascular; Humans; Lipoproteins, LDL; Mice; Oxidation-Reduction; Oxidative Stress; Scavenger Receptors, Class E | 2011 |
Cross talk between mitochondria and NADPH oxidases.
Topics: Aging; Angiotensin II; Animals; Antioxidants; Atherosclerosis; Diabetes Mellitus; Humans; Hypertension; Mice; Mitochondria; NADPH Oxidases; Neurodegenerative Diseases; Nitric Oxide Synthase Type III; Organophosphorus Compounds; Oxidation-Reduction; Oxidative Stress; Piperidines; Rabbits; Rats; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; Xanthine Oxidase | 2011 |
[Role of chronic inflammation in the pathogenesis of atherosclerosis].
Topics: Adipokines; Adipose Tissue; Angiotensin II; Animals; Atherosclerosis; Chronic Disease; Coronary Vessels; Cytokines; Humans; Inflammation; Inflammation Mediators; Life Style; Macrophages; Neovascularization, Pathologic; Plaque, Atherosclerotic; Vascular Endothelial Growth Factor A | 2011 |
[Pathophysiological role of tissue renin-angiotensin-aldosterone system (RAAS) in human atherosclerosis].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atherosclerosis; Cardiovascular Diseases; Humans; Renin-Angiotensin System; Treatment Outcome | 2012 |
Non-ACE pathway-induced angiotensin II production.
Topics: Angiotensin II; Angiotensinogen; Animals; Atherosclerosis; Chymases; Humans; Myocardium; Serine Endopeptidases | 2013 |
The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.
Topics: Angiotensin II; Atherosclerosis; Biomarkers; Coronary Artery Disease; Diabetes Mellitus; Endothelial Cells; Gene Expression Regulation; Humans; Hypertension; Lipoproteins, LDL; Myocardial Ischemia; Oxidative Stress; Predictive Value of Tests; Receptors, Oxidized LDL; Risk Factors; Scavenger Receptors, Class E; Sensitivity and Specificity; Severity of Illness Index; Signal Transduction | 2004 |
[Vascular NAD(P)H oxidases--role in the pathogenesis of atherosclerosis].
Topics: Angiotensin II; Atherosclerosis; Endothelium, Vascular; Humans; NADPH Oxidases; Superoxides | 2005 |
Spotlight on endothelial progenitor cell inhibitors: short review.
Topics: Angiotensin II; Animals; Arginine; Atherosclerosis; Bone Marrow Cells; Cell Differentiation; Cell Movement; Endothelial Cells; Humans; Lipoproteins, LDL; Nitric Oxide; Stem Cells | 2005 |
Role of angiotensin II receptor blockers in atherosclerotic plaque stability.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; Biphenyl Compounds; Carotid Arteries; Collagen; Cyclooxygenase 2; Humans; Hypertension; Irbesartan; Macrophages; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Randomized Controlled Trials as Topic; Tetrazoles | 2006 |
Pathophysiological regulation of the AT1-receptor and implications for vascular disease.
Topics: Angiotensin II; Atherosclerosis; Diabetes Complications; Estrogens; Humans; Hypercholesterolemia; Interleukin-6; Receptor, Angiotensin, Type 1 | 2006 |
Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension.
Topics: Angiotensin II; Atherosclerosis; Endothelium, Vascular; Humans; Hypertension; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Reactive Oxygen Species; Scavenger Receptors, Class E; Superoxides | 2006 |
[Renin-angiotensin system in atherosclerosis].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Disease Progression; Endothelium, Vascular; Humans; Inflammation; Reactive Oxygen Species; Renin-Angiotensin System | 2006 |
Calcium channel blockers, endothelial dysfunction, and combination therapy.
Topics: Aged; Angiotensin II; Antihypertensive Agents; Atherosclerosis; Calcium Channel Blockers; Drug Therapy, Combination; Endothelium, Vascular; Humans; Hypertension; Nitric Oxide; Reactive Oxygen Species | 2005 |
Neovascularization in human atherosclerosis.
Topics: Angiotensin II; Animals; Aryl Hydrocarbon Receptor Nuclear Translocator; Atherosclerosis; Blood Proteins; Capillary Permeability; Cell Hypoxia; Chemotaxis, Leukocyte; Coronary Artery Disease; Coronary Vessels; Diagnostic Imaging; Disease Progression; Hemorrhage; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Macrophage Activation; Membrane Lipids; Models, Animal; Neovascularization, Physiologic; Oxidative Stress; Sus scrofa; Sympathetic Nervous System; Tunica Intima; Vasa Vasorum; Vascular Endothelial Growth Factor A | 2006 |
Redox signaling in angiogenesis: role of NADPH oxidase.
Topics: Angiotensin II; Animals; Atherosclerosis; Endothelial Cells; Endothelial Growth Factors; Endothelium, Vascular; Humans; NADPH Oxidases; Neovascularization, Pathologic; Neovascularization, Physiologic; Oxidation-Reduction; Signal Transduction | 2006 |
Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Biomarkers; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; E-Selectin; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukins; Renin-Angiotensin System; Tumor Necrosis Factor-alpha | 2006 |
Hypertension in Cushing's syndrome.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Angiotensin II; Antihypertensive Agents; Atherosclerosis; Catecholamines; Cushing Syndrome; Glucocorticoids; Humans; Hypertension; Models, Biological; Renin-Angiotensin System; Vasoconstrictor Agents; Vasodilator Agents | 2006 |
Angiotensin, bradykinin and the endothelium.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Atherosclerosis; Bradykinin; Bradykinin Receptor Antagonists; Endothelium, Vascular; Humans; Hypertension; Inflammation; Peptides; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptors, Bradykinin; Signal Transduction | 2006 |
Macroangiopathy in adults and children with diabetes: from molecular mechanisms to vascular damage (part 1).
Topics: Adult; Angiotensin I; Angiotensin II; Atherosclerosis; Child; Cholesterol, LDL; Diabetic Angiopathies; Fatty Liver; Humans; Inflammation; Macrophages; Thrombosis | 2006 |
Vascular cell senescence: contribution to atherosclerosis.
Topics: Aging; Aging, Premature; Angiotensin II; Animals; Atherosclerosis; Blood Vessels; Cellular Senescence; Diabetic Angiopathies; DNA Damage; Humans; Mitochondria; Oxidative Stress; Syndrome; Telomere | 2007 |
Oxidative stress and endothelial dysfunction.
Topics: Angiotensin II; Atherosclerosis; Blood Coagulation; Endothelium, Vascular; Humans; Oxidative Stress | 2007 |
Lipid peroxidation, isoprostanes and vascular damage.
Topics: Angiotensin II; Animals; Atherosclerosis; Biomarkers; Endothelium, Vascular; Humans; Isoprostanes; Lipid Peroxidation; Oxidative Stress; Risk Factors | 2006 |
Diabetes mellitus and macrovascular disease: mechanisms and mediators.
Topics: Adiponectin; Angiotensin II; Animals; Atherosclerosis; Blood Coagulation; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Insulin Resistance; Peroxisome Proliferator-Activated Receptors | 2007 |
Role of bone marrow renin-angiotensin system in the pathogenesis of atherosclerosis.
Topics: Angiotensin II; Animals; Atherosclerosis; Bone Marrow; Humans; Inflammation; Mice; Mice, Knockout; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2008 |
220 other study(ies) available for angiotensin ii and Atherogenesis
| Article | Year |
|---|---|
Rewiring Vascular Metabolism Prevents Sudden Death due to Aortic Ruptures-Brief Report.
Topics: Angiotensin II; Animals; Aortic Rupture; Atherosclerosis; Death, Sudden; Humans; Mice; Mitochondrial Proteins | 2022 |
Renoprotective Effect of KLF2 on Glomerular Endothelial Dysfunction in Hypertensive Nephropathy.
Topics: Angiotensin II; Animals; Atherosclerosis; Endothelial Cells; Fibrosis; Humans; Hypertension, Renal; Interleukin-18; Kruppel-Like Transcription Factors; Mice; Nephritis; RNA, Messenger; Simvastatin; Transcription Factors | 2022 |
Soluble RAGE attenuates Ang II-induced arterial calcification via inhibiting AT1R-HMGB1-RAGE axis.
Topics: Angiotensin II; Animals; Atherosclerosis; Calcinosis; Calcium; HMGB1 Protein; Mice; Mice, Knockout; Receptor for Advanced Glycation End Products | 2022 |
Reducing Proteoglycan Synthesis and NOX Activity by ROCK Inhibitors: Therapeutic Targets in Atherosclerosis.
Topics: Angiotensin II; Atherosclerosis; Endothelin-1; Humans; Hypertension; Protein Serine-Threonine Kinases; Proteoglycans; Receptors, G-Protein-Coupled; rho-Associated Kinases; Serine | 2022 |
Activation of the GTPase ARF6 regulates invasion of human vascular smooth muscle cells by stimulating MMP14 activity.
Topics: ADP-Ribosylation Factor 6; Angiotensin II; Atherosclerosis; Cell Movement; Cells, Cultured; Humans; Matrix Metalloproteinase 14; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet-Derived Growth Factor | 2022 |
Edaravone Attenuated Angiotensin II-Induced Atherosclerosis and Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm; Aortic Aneurysm, Abdominal; Atherosclerosis; Edaravone; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, LDL; RNA, Messenger | 2022 |
The Nonproteolytic Intracellular Domain of Membrane-Type 1 Matrix Metalloproteinase Coordinately Modulates Abdominal Aortic Aneurysm and Atherosclerosis in Mice-Brief Report.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Atherosclerosis; Cholesterol; Elastin; Matrix Metalloproteinase 14; Mice; Netrin-1; Proprotein Convertase 9; Subtilisins | 2022 |
Tripeptide Leu-Ser-Trp Regulates the Vascular Endothelial Cells Phenotype Switching by Mediating the Vascular Smooth Muscle Cells-Derived Small Extracellular Vesicles Packaging of miR-145.
Topics: Angiotensin II; Apoptosis Regulatory Proteins; Atherosclerosis; Endothelial Cells; Extracellular Vesicles; Humans; Lipoproteins, LDL; MicroRNAs; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenotype; RNA-Binding Proteins; Soybean Proteins | 2022 |
LOX-1 deficiency increases ruptured abdominal aortic aneurysm via thinning of adventitial collagen.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Atherosclerosis; Collagen; Disease Models, Animal; Inflammation; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Plaque, Atherosclerotic; Scavenger Receptors, Class E | 2023 |
Klotho ameliorates angiotension-II-induced endothelial senescence via restoration of autophagy by inhibiting Wnt3a/GSK-3β/mTOR signaling: A potential mechanism involved in prognostic performance of Klotho in coronary atherosclerotic disease.
Topics: Angiotensin II; Atherosclerosis; Autophagy; Cellular Senescence; Glycogen Synthase Kinase 3 beta; Humans; Klotho Proteins; Prognosis; Signal Transduction; TOR Serine-Threonine Kinases; Wnt3A Protein | 2023 |
Vascular Ultrasound for In Vivo Assessment of Arterial Pathologies in a Murine Model of Atherosclerosis and Aortic Aneurysm.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Atherosclerosis; Carotid Intima-Media Thickness; Collagen; Disease Models, Animal; Mice; Mice, Inbred C57BL | 2023 |
Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT
Topics: ADAM17 Protein; Angiotensin II; Animals; Atherosclerosis; c-Mer Tyrosine Kinase; Humans; Macrophages; Mice, Transgenic; p38 Mitogen-Activated Protein Kinases; Phagocytosis; Protein-Tyrosine Kinases; Reactive Oxygen Species; Receptor Protein-Tyrosine Kinases | 2019 |
Novel interaction of antioxidant-1 with TRAF4: role in inflammatory responses in endothelial cells.
Topics: Angiotensin II; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Copper; Copper Transport Proteins; Diet, High-Fat; Gene Expression Regulation; HEK293 Cells; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Intercellular Adhesion Molecule-1; Male; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Molecular Chaperones; NADPH Oxidases; Protein Binding; Protein Transport; Reactive Oxygen Species; RNA, Small Interfering; TNF Receptor-Associated Factor 4; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2019 |
Soluble RAGE attenuates AngII-induced endothelial hyperpermeability by disrupting HMGB1-mediated crosstalk between AT1R and RAGE.
Topics: Angiotensin II; Animals; Antigens, CD; Antigens, Neoplasm; Aorta; Atherosclerosis; Cadherins; Capillary Permeability; Cardiovascular Diseases; Endothelial Cells; HMGB1 Protein; Human Umbilical Vein Endothelial Cells; Humans; Hypertension; Inflammation; Ligands; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Receptor, Angiotensin, Type 1; RNA, Small Interfering; Signal Transduction | 2019 |
Invited commentary.
Topics: Angiotensin II; Animals; Aortic Rupture; Atherosclerosis; Male; Mice | 2019 |
Depletion of CD11c+ dendritic cells in apolipoprotein E-deficient mice limits angiotensin II-induced abdominal aortic aneurysm formation and growth.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Atherosclerosis; CD11 Antigens; Cholesterol; Dendritic Cells; Leukocyte Elastase; Lymphocyte Count; Male; Mice, Knockout, ApoE; Random Allocation; Vascular Remodeling | 2019 |
Repeated Porphyromonas gingivalis W83 exposure leads to release pro-inflammatory cytokynes and angiotensin II in coronary artery endothelial cells.
Topics: Angiotensin II; Atherosclerosis; Chemokine CCL2; Coronary Vessels; Endothelial Cells; Flow Cytometry; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hypertension; Inflammation; Interleukin-6; Lipopolysaccharides; Periodontitis; Porphyromonas gingivalis; Receptor, Angiotensin, Type 1; RNA, Messenger | 2019 |
Anti-Inflammatory and Antioxidant Effects of Acetyl-L-Carnitine on Atherosclerotic Rats.
Topics: Acetylcarnitine; Adiponectin; Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Aorta; Atherosclerosis; Biomarkers; C-Reactive Protein; Inflammation Mediators; Interleukin-1beta; Lipids; Male; Myocardium; Nitric Oxide Synthase Type II; Oxidative Stress; Rats, Wistar; Reactive Oxygen Species; RNA, Messenger; Tumor Necrosis Factor-alpha | 2020 |
Bmal1 Deletion in Myeloid Cells Attenuates Atherosclerotic Lesion Development and Restrains Abdominal Aortic Aneurysm Formation in Hyperlipidemic Mice.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; ARNTL Transcription Factors; Atherosclerosis; Cells, Cultured; Crosses, Genetic; Diet, High-Fat; Gene Deletion; Gene Expression; Hyperlipidemias; Inflammation; Integrases; Macrophages, Peritoneal; Mice; Mice, Knockout; Muramidase; Myeloid Cells; Promoter Regions, Genetic; Receptors, LDL | 2020 |
Two Amino Acids Proximate to the Renin Cleavage Site of Human Angiotensinogen Do Not Affect Blood Pressure and Atherosclerosis in Mice-Brief Report.
Topics: Amino Acid Substitution; Angiotensin II; Angiotensinogen; Animals; Atherosclerosis; Blood Pressure; Disease Models, Animal; Female; Hepatocytes; Humans; Hypertension; Male; Mice, Knockout; Plaque, Atherosclerotic; Receptors, LDL; Renin; Species Specificity | 2020 |
Smooth muscle NADPH oxidase 4 promotes angiotensin II-induced aortic aneurysm and atherosclerosis by regulating osteopontin.
Topics: Angiotensin II; Animals; Aortic Aneurysm; Atherosclerosis; Humans; Mice; Mice, Inbred Strains; Mice, Knockout; Mice, Transgenic; NADPH Oxidase 4; Osteopontin | 2020 |
Preventive Effects of Quercetin against the Onset of Atherosclerosis-Related Acute Aortic Syndromes in Mice.
Topics: Aminopropionitrile; Angiotensin II; Animals; Aorta, Thoracic; Aortic Aneurysm; Aortic Dissection; Atherosclerosis; Blood Pressure; Disease Models, Animal; Humans; Hypertension; Mice; Protein-Lysine 6-Oxidase; Quercetin | 2020 |
C1q/TNF-related protein-9 is elevated in hypertension and associated with the occurrence of hypertension-related atherogenesis.
Topics: Adipokines; Adiponectin; Adult; Aged; Angiotensin II; Animals; Atherosclerosis; Carotid Artery Diseases; Complement C1q; Endothelial Cells; Female; Glycoproteins; Humans; Hypertension; Male; Mice; Mice, Inbred C57BL; Middle Aged | 2021 |
Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II-Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertension.
Topics: Aminobutyrates; Angiotensin II; Animals; Antihypertensive Agents; Atherosclerosis; Biphenyl Compounds; Mice; Neprilysin | 2021 |
Effects of Endogenous Angiotensin II on Abdominal Aortic Aneurysms and Atherosclerosis in Angiotensin II-Infused Mice.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Atherosclerosis; Disease Models, Animal; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Vasoconstrictor Agents | 2021 |
NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat Diet.
Topics: Administration, Oral; Angiotensin II; Angiotensinogen; Animals; Atherosclerosis; Chlorogenic Acid; Commiphora; Curcumin; Diet, High-Fat; Dietary Supplements; Fatty Acid-Binding Proteins; Gene Expression Regulation; Inulin; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Neoplasm Proteins; Non-alcoholic Fatty Liver Disease; Plant Extracts; Plant Gums; RNA, Messenger; Silymarin; Suppressor of Cytokine Signaling 3 Protein | 2017 |
Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) induces anti-hyperlipidemia leading to reduction of angiotensin II-induced aneurysm development.
Topics: Angiotensin II; Animals; Aortic Aneurysm; Atherosclerosis; Disease Models, Animal; Heparin-binding EGF-like Growth Factor; Hyperlipidemias; Liver; Male; Mice; Receptors, LDL | 2017 |
Leukocyte RhoA exchange factor Arhgef1 mediates vascular inflammation and atherosclerosis.
Topics: Angiotensin II; Animals; Atherosclerosis; Disease Models, Animal; Inflammation; Leukocytes; Mice; Mice, Knockout; Receptors, LDL; Rho Guanine Nucleotide Exchange Factors; Vasculitis | 2017 |
Regulation of angiotensin II actions by enhancers and super-enhancers in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta; Atherosclerosis; Azepines; Cells, Cultured; Gene Expression Regulation; Histones; Hypertension; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rats, Sprague-Dawley; RNA, Long Noncoding; Signal Transduction; Triazoles | 2017 |
Angiotensin II Infusion Does Not Cause Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Rats.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Dissection; Apolipoproteins E; Atherosclerosis; Blood Pressure; Cholesterol; Disease Models, Animal; Gene Knockout Techniques; Genetic Predisposition to Disease; Phenotype; Rats, Sprague-Dawley; Rats, Transgenic; Time Factors; Ultrasonography, Doppler | 2018 |
Anti-Atherogenic Activity of Polyphenol-Rich Extract from Bee Pollen.
Topics: Angiotensin II; Animals; Arginine; Atherosclerosis; Bees; Cholesterol; Coronary Artery Disease; Diet, High-Fat; Dose-Response Relationship, Drug; Female; Hypercholesterolemia; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Peptidyl-Dipeptidase A; Pollen; Polyphenols | 2017 |
Loss of vascular smooth muscle cell autophagy exacerbates angiotensin II-associated aortic remodeling.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Atherosclerosis; Autophagy; Hemodynamics; Mice; Mice, Knockout; Muscle, Smooth, Vascular | 2018 |
Dose-Effect of Irbesartan on Cyclooxygenase-2 and Matrix Metalloproteinase-9 Expression in Rabbit Atherosclerosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Aortic Diseases; Atherosclerosis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Irbesartan; Lipids; Male; Matrix Metalloproteinase 9; NF-kappa B; Plaque, Atherosclerotic; Rabbits; Signal Transduction | 2018 |
Cilostazol Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysms but Not Atherosclerosis in Apolipoprotein E-Deficient Mice.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Atherosclerosis; Cell Adhesion Molecules; Cells, Cultured; Cilostazol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytokines; Dilatation, Pathologic; Disease Models, Animal; Endothelial Cells; Male; Mice, Knockout, ApoE; Phosphodiesterase 3 Inhibitors; Signal Transduction | 2018 |
Lipid-Lowering Therapy With Ezetimibe Decreases Spontaneous Atherothrombotic Occlusions in a Rabbit Model of Plaque Erosion: A Role of Serum Oxysterols.
Topics: Angiotensin II; Animals; Anticholesteremic Agents; Arterial Occlusive Diseases; Atherosclerosis; Biomarkers; Cells, Cultured; Cholesterol, Dietary; Diet, High-Fat; Disease Models, Animal; Down-Regulation; Ezetimibe; Femoral Artery; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Oxysterols; Plaque, Atherosclerotic; Rabbits; Rats; Rosuvastatin Calcium; Signal Transduction; Thrombosis; Vascular System Injuries | 2018 |
Astragaloside IV inhibits Angiotensin II-stimulated proliferation of rat vascular smooth muscle cells via the regulation of CDK2 activity.
Topics: Angiotensin II; Animals; Atherosclerosis; Cell Line; Cyclin-Dependent Kinase 2; G1 Phase; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; S Phase; Saponins; Triterpenes; Vascular Remodeling | 2018 |
Plasma cholesterol lowering in an AngII‑infused atherosclerotic mouse model with moderate hypercholesterolemia.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoprotein B-100; Atherosclerosis; Cholesterol; Disease Models, Animal; Gene Expression Regulation; Hypercholesterolemia; Integrases; Male; Receptors, LDL | 2018 |
Urolithin A shows anti-atherosclerotic activity via activation of class B scavenger receptor and activation of Nef2 signaling pathway.
Topics: Angiotensin II; Animals; Aorta; Atherosclerosis; CD36 Antigens; Coumarins; Hypercholesterolemia; Lipids; Male; MAP Kinase Signaling System; NF-E2-Related Factor 2; Rats; Rats, Wistar; Receptors, Scavenger; Signal Transduction; Up-Regulation | 2018 |
Effect of irradiation and bone marrow transplantation on angiotensin II-induced aortic inflammation in ApoE knockout mice.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aortic Rupture; Aortitis; Atherosclerosis; Bone Marrow Transplantation; Disease Models, Animal; Macrophages; Male; Mice, Knockout, ApoE; Monocytes; Plaque, Atherosclerotic; Whole-Body Irradiation | 2018 |
TRAIL protects against endothelial dysfunction in vivo and inhibits angiotensin-II-induced oxidative stress in vascular endothelial cells in vitro.
Topics: Aldehydes; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Diet, High-Fat; Endothelial Cells; Humans; Mice; Nitric Oxide Synthase Type III; Oxidative Stress; Reactive Oxygen Species; TNF-Related Apoptosis-Inducing Ligand; Vascular Cell Adhesion Molecule-1; Vasodilation | 2018 |
A diet enriched with tree nuts reduces severity of atherosclerosis but not abdominal aneurysm in angiotensin II-infused apolipoprotein E deficient mice.
Topics: Angiotensin II; Animal Feed; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Aortic Diseases; Atherosclerosis; Brachiocephalic Trunk; Dilatation, Pathologic; Disease Models, Animal; Fatty Acids, Omega-3; Male; Mice, Knockout, ApoE; Nutritive Value; Nuts; Plaque, Atherosclerotic; Polyphenols; Severity of Illness Index; Time Factors | 2018 |
Genistein inhibits Ang II-induced CRP and MMP-9 generations via the ER-p38/ERK1/2-PPARγ-NF-κB signaling pathway in rat vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Atherosclerosis; C-Reactive Protein; Cells, Cultured; Dose-Response Relationship, Drug; Genistein; Inflammation; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; PPAR gamma; Rats; Rats, Sprague-Dawley; Time Factors | 2019 |
Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief Report.
Topics: Angiotensin II; Angiotensinogen; Animals; Atherosclerosis; Female; Hypercholesterolemia; Low Density Lipoprotein Receptor-Related Protein-2; Male; Mice; Mice, Inbred C57BL; Oligonucleotides, Antisense; Renin-Angiotensin System | 2019 |
Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Diseases; Arrhythmias, Cardiac; Arterial Pressure; Atherosclerosis; Cardiomegaly; Disease Models, Animal; Hypertension; Male; Mice, Knockout, ApoE; Plaque, Atherosclerotic; Propionates; T-Lymphocytes, Regulatory; Th17 Cells | 2019 |
An important role of matrix metalloproteinase-8 in angiogenesis in vitro and in vivo.
Topics: Aneurysm; Angiotensin I; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; beta Catenin; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Gene Knockdown Techniques; Human Umbilical Vein Endothelial Cells; Humans; Matrix Metalloproteinase 8; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Neovascularization, Physiologic; Plaque, Atherosclerotic; Platelet Endothelial Cell Adhesion Molecule-1; RNA Interference; Time Factors; Transfection | 2013 |
PD123319 augments angiotensin II-induced abdominal aortic aneurysms through an AT2 receptor-independent mechanism.
Topics: Angiotensin II; Animals; Aorta; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Atherosclerosis; Genotype; Imidazoles; Male; Mice; Mice, Inbred C57BL; Pyridines; Receptor, Angiotensin, Type 2 | 2013 |
Vascular angiotensin II type 2 receptor attenuates atherosclerosis via a kinin/NO-dependent mechanism.
Topics: Angiotensin II; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Bradykinin; Calcium; Kinins; Macrophages; Mice, Inbred C57BL; Mice, Transgenic; Monocytes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Receptor, Angiotensin, Type 2; Superoxides; Vascular Cell Adhesion Molecule-1 | 2015 |
Prevention of TGFβ induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr-/- mice.
Topics: Angiotensin II; Animals; Atherosclerosis; Biglycan; Disease Models, Animal; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Receptors, LDL; Transforming Growth Factor beta | 2013 |
Periaortic adipose tissue-specific activation of the renin-angiotensin system contributes to atherosclerosis development in uninephrectomized apoE-/- mice.
Topics: Adipocytes; Adipose Tissue; Angiotensin II; Angiotensinogen; Animals; Aorta, Thoracic; Apolipoproteins E; Atherosclerosis; Cholesterol, Dietary; Disease Models, Animal; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nephrectomy; PPAR gamma; Renal Insufficiency, Chronic; Renin-Angiotensin System | 2013 |
Contributions of leukocyte angiotensin-converting enzyme to development of atherosclerosis.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atherosclerosis; Bone Marrow Transplantation; Cells, Cultured; Diet, High-Fat; Disease Models, Animal; Enalapril; Hypercholesterolemia; Leukocytes; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptidyl-Dipeptidase A; Receptors, LDL; Transplantation Chimera | 2013 |
Cathepsin G deficiency decreases complexity of atherosclerotic lesions in apolipoprotein E-deficient mice.
Topics: Angiotensin II; Animals; Aorta; Apolipoproteins E; Apoptosis; Atherosclerosis; Cathepsin G; Diet, High-Fat; Macrophages; Male; Mice; Mice, Knockout; Phagocytosis; Plaque, Atherosclerotic | 2013 |
The effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient mice.
Topics: Angiotensin II; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Biomarkers; Blood Pressure; Cell Adhesion Molecules; Gene Expression Regulation; Gene Knockout Techniques; Humans; Inflammation; Male; Mice; Muscle, Smooth, Vascular; Plaque, Atherosclerotic; Rats; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Solubility | 2013 |
The influence of angiotensin-(1-7) peptidomimetic (AVE 0991) and nebivolol on angiotensin I metabolism in aorta of apoE-knockout mice.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Aorta, Thoracic; Apolipoproteins E; Atherosclerosis; Benzopyrans; Down-Regulation; Drug Therapy, Combination; Ethanolamines; Female; Imidazoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Nebivolol; Peptide Fragments; Renin-Angiotensin System; Vasodilator Agents | 2013 |
Effect of aerobic exercise on miRNA-TLR4 signaling in atherosclerosis.
Topics: Angiotensin II; Animals; Atherosclerosis; Disease Models, Animal; Endothelin-1; Epidermal Growth Factor; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; MicroRNAs; NF-kappa B; Physical Conditioning, Animal; Signal Transduction; TNF Receptor-Associated Factor 6; Toll-Like Receptor 4 | 2014 |
High sodium augments angiotensin II-induced vascular smooth muscle cell proliferation through the ERK 1/2-dependent pathway.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Atherosclerosis; Blotting, Western; Cell Proliferation; Cells, Cultured; Chlorides; Culture Media; Hydrogen-Ion Concentration; Immunoprecipitation; Male; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Osmolar Concentration; Phosphorylation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Sodium; Sodium Channels; Thymidine; Vasoconstrictor Agents | 2014 |
Subservient relationship of the peripheral second systolic pressure peak to the central hemodynamic parameters is preserved, irrespective of atherosclerosis progression in hypercholesterolemic rabbits.
Topics: Angiotensin II; Animals; Atherosclerosis; Blood Pressure; Disease Progression; Hemodynamics; Hypercholesterolemia; Hypertension; Male; Nitroprusside; Rabbits; Vasoconstrictor Agents; Vasodilator Agents | 2014 |
Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice.
Topics: Angiotensin I; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Blood Pressure; Disease Models, Animal; Female; Hypertension, Renal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naphthalenes; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyrazoles; Receptors, G-Protein-Coupled; Renal Circulation; Vascular Resistance | 2014 |
Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Femoral Artery; Gene Deletion; Genetic Predisposition to Disease; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Peptidyl-Dipeptidase A; Phenotype; Plaque, Atherosclerotic; Protein Kinase Inhibitors; RNA Interference; Signal Transduction; Transfection; Vascular System Injuries | 2014 |
Amlodipine reduces AngII-induced aortic aneurysms and atherosclerosis in hypercholesterolemic mice.
Topics: Amlodipine; Angiotensin II; Animals; Aortic Aneurysm; Atherosclerosis; Hyperlipoproteinemia Type II; Male; Mice; Mice, Knockout; Receptors, LDL | 2013 |
Cellular and molecular mechanisms in vascular smooth muscle cells by which total saponin extracted from Tribulus terrestris protects against artherosclerosis.
Topics: Angiotensin II; Animals; Atherosclerosis; Calcium; Cattle; Cell Proliferation; Cells, Cultured; Gene Expression Regulation; Genes, fos; Hydrogen Peroxide; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Saponins; Tribulus | 2013 |
Rosuvastatin attenuates atherosclerosis in rats via activation of scavenger receptor class B type I.
Topics: Angiotensin II; Animals; Aorta; Atherosclerosis; Cholesterol; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Pyrimidines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger; Rosuvastatin Calcium; Scavenger Receptors, Class B; Sulfonamides; Triglycerides; Up-Regulation | 2014 |
Angiotensin-induced abdominal aortic aneurysms in hypercholesterolemic mice: role of serum cholesterol and temporal effects of exposure.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Cholesterol; Elastin; Hypercholesterolemia; Macrophages; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Time Factors; Ultrasonography | 2014 |
Adiponectin expression protects against angiotensin II-mediated inflammation and accelerated atherosclerosis.
Topics: Adiponectin; Angiotensin II; Animals; Apolipoproteins; Atherosclerosis; Blood Pressure; Cholesterol; Disease Models, Animal; Gene Expression; Hypertension; Inflammation; Liver; Macrophages; Male; Mice; Mice, Knockout; Protein Multimerization; Protein Transport; Receptors, Adiponectin; Receptors, LDL; Receptors, Scavenger | 2014 |
Aliskiren limits abdominal aortic aneurysm, ventricular hypertrophy and atherosclerosis in an apolipoprotein-E-deficient mouse model.
Topics: Amides; Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Blood Pressure; Disease Models, Animal; Fumarates; Hypertension; Hypertrophy; Mice; Mice, Inbred C57BL; Mice, Knockout | 2014 |
MicroRNA-365 inhibits the proliferation of vascular smooth muscle cells by targeting cyclin D1.
Topics: Angiotensin II; Animals; Atherosclerosis; Becaplermin; Carotid Arteries; Carotid Artery Injuries; Cell Division; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclin D1; Down-Regulation; MicroRNAs; Muscle, Smooth, Vascular; Neointima; Proliferating Cell Nuclear Antigen; Protein Binding; Proto-Oncogene Proteins c-sis; Rats; RNA-Binding Proteins; S Phase Cell Cycle Checkpoints | 2014 |
Uremic conditions drive human monocytes to pro-atherogenic differentiation via an angiotensin-dependent mechanism.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Captopril; Cell Adhesion; Cell Line; Cell Movement; Cell Proliferation; Humans; Lipopolysaccharides; Losartan; Monocytes; Peptidyl-Dipeptidase A; Uremia | 2014 |
Biglycan deficiency: increased aortic aneurysm formation and lack of atheroprotection.
Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm; Atherosclerosis; Biglycan; Diet, Western; Female; Genotype; Heparan Sulfate Proteoglycans; Male; Mice, Inbred C57BL; Rupture; Survival Analysis | 2014 |
Renin inhibition reduces atherosclerotic plaque neovessel formation and regresses advanced atherosclerotic plaques.
Topics: Amides; Angiotensin II; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Blood Pressure; Carrier Proteins; Cathepsins; Chemokine CCL2; Extracellular Matrix; Fumarates; Gene Silencing; Human Umbilical Vein Endothelial Cells; Humans; Hydralazine; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Nuclear Proteins; Plaque, Atherosclerotic; Receptor, Angiotensin, Type 1; Renin; Toll-Like Receptor 2; Treatment Outcome; Vascular Cell Adhesion Molecule-1 | 2014 |
A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin II-infused apolipoprotein-E-deficient mouse.
Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Aorta; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Cytokines; Disease Models, Animal; Disease Progression; Elastin; Inflammation Mediators; Injections, Intraperitoneal; Male; Mice, Knockout; Peptides; Phosphorylation; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Smad2 Protein; Smad3 Protein; Thrombospondin 1; Time Factors; Transforming Growth Factor beta1 | 2015 |
Valsartan Attenuates Atherosclerosis via Upregulating the Th2 Immune Response in Prolonged Angiotensin II-Treated ApoE(-/-) Mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antibodies, Monoclonal; Apolipoproteins E; Atherosclerosis; Blood Pressure; Body Weight; Disease Models, Animal; Inflammation; Interleukin-5; Lipids; Male; Mice; Mice, Knockout; Plaque, Atherosclerotic; T-Lymphocyte Subsets; Th2 Cells; Valsartan | 2015 |
Cys18-Cys137 disulfide bond in mouse angiotensinogen does not affect AngII-dependent functions in vivo.
Topics: Angiotensin II; Angiotensinogen; Animals; Atherosclerosis; Blood Pressure; Disease Models, Animal; DNA; DNA Mutational Analysis; Mice; Mutation; Renin; Renin-Angiotensin System | 2015 |
ACE2 and Ang-(1-7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Apolipoproteins E; Atherosclerosis; Cell Adhesion; Cell Movement; Chemokine CCL2; Disease Models, Animal; E-Selectin; Endothelium, Vascular; Gene Transfer Techniques; Humans; In Vitro Techniques; Inflammation; Mice; Peptide Fragments; Peptidyl-Dipeptidase A; Signal Transduction; Vascular Cell Adhesion Molecule-1 | 2015 |
Angiotensin-(1-7) stimulates cholesterol efflux from angiotensin II-treated cholesterol-loaded THP-1 macrophages through the suppression of p38 and c-Jun N-terminal kinase signaling.
Topics: Angiotensin I; Angiotensin II; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; Cholesterol; Gene Expression Regulation, Enzymologic; Humans; JNK Mitogen-Activated Protein Kinases; Liver X Receptors; Macrophages; Orphan Nuclear Receptors; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; PPAR gamma; Renin-Angiotensin System; RNA, Messenger | 2015 |
Amelioration of Atherosclerosis by the New Medicinal Mushroom Grifola gargal Singer.
Topics: Agaricales; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Biological Products; Blood Vessels; Chemokine CCL2; Chemokine CXCL12; Disease Models, Animal; Fibroblasts; Granulocytes; Grifola; Heart; Injections, Intraperitoneal; Mice; T-Lymphocytes, Regulatory; Transforming Growth Factor beta1; Treatment Outcome; Vascular Endothelial Growth Factor A | 2015 |
Development of a sensitive, accurate and robust liquid chromatography/mass spectrometric method for profiling of angiotensin peptides in plasma and its application for atherosclerotic mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensins; Animals; Apolipoproteins E; Atherosclerosis; Chromatography, Liquid; Mass Spectrometry; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Receptors, LDL | 2015 |
Protective role of oleic acid against cardiovascular insulin resistance and in the early and late cellular atherosclerotic process.
Topics: Angiotensin II; Animals; Apoptosis; Atherosclerosis; Blotting, Western; Cell Line; Cell Proliferation; Chemokine CCL2; Inflammation; Insulin Resistance; Intercellular Adhesion Molecule-1; MAP Kinase Signaling System; Mice; Muscle, Smooth, Vascular; Myocytes, Cardiac; Myocytes, Smooth Muscle; NF-kappa B; Nitric Oxide Synthase Type III; Oleic Acid; Palmitates; Palmitic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents | 2015 |
Fibroblast Angiotensin II Type 1a Receptors Contribute to Angiotensin II-Induced Medial Hyperplasia in the Ascending Aorta.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Atherosclerosis; Disease Models, Animal; DNA; Fibroblasts; Gene Expression Regulation; Genotype; Hyperplasia; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Angiotensin, Type 1; RNA, Messenger; Tunica Media | 2015 |
Angiotensin II Promotes Atherogenesis through upregulating the Expression of Connexin 43 in Dendritic Cells.
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Blood Pressure; CD40 Antigens; Cells, Cultured; Connexin 43; Dendritic Cells; Immunohistochemistry; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Smooth Muscle; Up-Regulation; Valsartan | 2015 |
The Sirt1 activator SRT1720 attenuates angiotensin II-induced atherosclerosis in apoE⁻/⁻ mice through inhibiting vascular inflammatory response.
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Heterocyclic Compounds, 4 or More Rings; Inflammation Mediators; Macrophages; Male; Mice; Mice, Knockout; Myocytes, Smooth Muscle; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Sirtuin 1 | 2015 |
Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Carotid Arteries; Collagen; Diminazene; Disease Models, Animal; Intercellular Adhesion Molecule-1; Macrophages; Mice; Mice, Inbred C57BL; Peptidyl-Dipeptidase A; Plaque, Atherosclerotic; Vascular Cell Adhesion Molecule-1 | 2015 |
Voluntary Exercise Stabilizes Established Angiotensin II-Dependent Atherosclerosis in Mice through Systemic Anti-Inflammatory Effects.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Apolipoproteins E; Atherosclerosis; Biomarkers; CD4-Positive T-Lymphocytes; Cytokines; Disease Models, Animal; Inflammation Mediators; Macrophages; Mice; Mice, Knockout; Phenotype; Physical Conditioning, Animal; Plaque, Atherosclerotic | 2015 |
Angiotensinogen Exerts Effects Independent of Angiotensin II.
Topics: Amides; Amino Acid Sequence; Angiotensin II; Angiotensinogen; Animals; Atherosclerosis; Blood Pressure; Conserved Sequence; Dependovirus; Diet, High-Fat; Disease Models, Animal; Fatty Liver; Fumarates; Genetic Vectors; Genotype; Hepatocytes; Hypertension; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Models, Molecular; Oligonucleotides, Antisense; Phenotype; Protein Binding; Protein Interaction Domains and Motifs; Receptors, LDL; Renin; Signal Transduction; Time Factors; Transduction, Genetic; Weight Gain | 2016 |
ATRQβ-001 vaccine prevents atherosclerosis in apolipoprotein E-null mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antibodies, Neutralizing; Aorta; Apolipoproteins E; Apoptosis; Atherosclerosis; Chemokine CCL2; Coronary Vessels; Endothelial Cells; Humans; Macrophages; Male; Mice; Mice, Knockout; Plaque, Atherosclerotic; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Scavenger Receptors, Class E; Vaccines; Valsartan; Vasoconstrictor Agents | 2016 |
Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice.
Topics: Administration, Intravenous; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Brachiocephalic Trunk; Cardiovascular Agents; Cathepsins; Cell Differentiation; Cells, Cultured; Chemistry, Pharmaceutical; Cytokines; Diet, High-Fat; Disease Models, Animal; Disease Progression; Drug Carriers; Inflammation Mediators; Lactic Acid; Macrophages, Peritoneal; Male; Matrix Metalloproteinases; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Nanoparticles; Phenotype; Pioglitazone; Plaque, Atherosclerotic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rupture, Spontaneous; Thiazolidinediones | 2016 |
Synergistic effect of atorvastatin and Cyanidin-3-glucoside on angiotensin II-induced inflammation in vascular smooth muscle cells.
Topics: Angiotensin II; Anthocyanins; Anti-Inflammatory Agents; Atherosclerosis; Atorvastatin; Cell Proliferation; Cells, Cultured; Drug Evaluation, Preclinical; Drug Synergism; Enzyme Induction; Glucosides; Humans; Intercellular Adhesion Molecule-1; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Nitric Oxide Synthase Type II; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Vascular Cell Adhesion Molecule-1; Vasculitis | 2016 |
Leukocyte Calpain Deficiency Reduces Angiotensin II-Induced Inflammation and Atherosclerosis But Not Abdominal Aortic Aneurysms in Mice.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Atherosclerosis; Bone Marrow Transplantation; Calcium-Binding Proteins; Calpain; Cell Adhesion; Cell Movement; Cells, Cultured; Coculture Techniques; Cysteine Proteinase Inhibitors; Diet, High-Fat; Disease Models, Animal; Endothelial Cells; Genetic Predisposition to Disease; Inflammation; Leukocytes; Macrophages; Male; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Phenotype; Receptors, LDL; Whole-Body Irradiation | 2016 |
Mitochondria-targeted esculetin alleviates mitochondrial dysfunction by AMPK-mediated nitric oxide and SIRT3 regulation in endothelial cells: potential implications in atherosclerosis.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Antioxidants; Aorta; Apolipoproteins E; Apoptosis; Atherosclerosis; Cell Survival; Cells, Cultured; Endothelial Cells; Humans; Hydrogen Peroxide; Male; Membrane Potential, Mitochondrial; Mice; Mice, Knockout; Microscopy, Confocal; Mitochondria; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Oxygen Consumption; Phosphorylation; RNA Interference; RNA, Small Interfering; Sirtuin 3; Umbelliferones | 2016 |
IMPACT OF RISK FACTOR FOR ATHEROSCLEROSIS ON MICROVASCULAR ENDOTHELIAL FUNCTION: AN IN VITRO STUDY.
Topics: Angiotensin II; Atherosclerosis; Blood Glucose; Cell Line; Cholesterol, LDL; Endothelin-1; Endothelium, Vascular; Healthy Volunteers; Humans; Interleukin-6; Microcirculation; Nitric Oxide; Nitric Oxide Synthase Type III | 2015 |
Uric acid stimulates proliferative pathways in vascular smooth muscle cells through the activation of p38 MAPK, p44/42 MAPK and PDGFRβ.
Topics: Angiotensin II; Animals; Atherosclerosis; Cardiovascular Diseases; Cell Proliferation; Gene Expression Regulation; Humans; Hypertension; Hyperuricemia; Losartan; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Receptor, Angiotensin, Type 1; Receptor, Platelet-Derived Growth Factor beta; Uric Acid | 2017 |
Imbalance between angiotensin II and angiotensin-(1-7) in human coronary atherosclerosis.
Topics: Angiotensin I; Angiotensin II; Atherosclerosis; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Peptide Fragments; Tumor Necrosis Factor-alpha | 2016 |
Angiotensin II increases coronary fibrosis, cardiac hypertrophy and the incidence of myocardial infarctions in ApoE
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Cardiomegaly; Disease Models, Animal; Fibrillin-1; Mice; Myocardial Infarction; Myocardium; Organ Size; Peptide Fragments; Treatment Outcome | 2016 |
Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Atherosclerosis by Affecting Foam Cell Formation and Efferocytosis.
Topics: Angiotensin II; Animals; Apoptosis; Atherosclerosis; Cholesterol; Disease Models, Animal; Female; Foam Cells; Male; Mice; Mice, Knockout; Receptors, Mineralocorticoid; Up-Regulation | 2017 |
"Osteotropic" Wnt/LRP Signals: High-Wire Artists in a Balancing Act Regulating Aortic Structure and Function.
Topics: Angiotensin II; Aortic Aneurysm; Atherosclerosis; Humans; Wnt Proteins; Wnt Signaling Pathway | 2017 |
Angiotensin-(1-7) regulates angiotensin II-induced matrix metalloproteinase-8 in vascular smooth muscle cells.
Topics: Angiotensin I; Angiotensin II; Animals; Atherosclerosis; Cells, Cultured; Disease Models, Animal; Enzyme Activation; Humans; Matrix Metalloproteinase 8; Mice, Knockout, ApoE; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Plaque, Atherosclerotic; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Time Factors | 2017 |
Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Dietary Fats; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Genetic Therapy; Humans; Male; Mice; Mice, Knockout; Neovascularization, Physiologic; Peptidyl-Dipeptidase A; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Transduction, Genetic; Vasodilation | 2008 |
Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis.
Topics: Adipokines; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aortic Aneurysm, Abdominal; Apelin; Apelin Receptors; Atherosclerosis; Blood Vessels; Carrier Proteins; Cell Nucleus; Diet; Disease Models, Animal; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Knockout; Nitric Oxide; Reactive Oxygen Species; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Signal Transduction; Vasoconstrictor Agents | 2008 |
Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model.
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Diet, Atherogenic; Disease Models, Animal; Epoxide Hydrolases; Inhibitory Concentration 50; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Structure; Molecular Weight; Pilot Projects; Solubility | 2008 |
Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosis.
Topics: Angiotensin II; Animals; Apolipoproteins E; Arteries; Atherosclerosis; Bone Marrow; Bone Marrow Transplantation; Chemokine CCL2; Chemotaxis, Leukocyte; Chimera; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Oxidative Stress; Receptor, Angiotensin, Type 1; Receptors, CCR2; Vasoconstrictor Agents | 2008 |
Angiotensin II upregulates acyl-CoA:cholesterol acyltransferase-1 via the angiotensin II Type 1 receptor in human monocyte-macrophages.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Atherosclerosis; Benzimidazoles; Biphenyl Compounds; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Endocytosis; Foam Cells; Humans; Imidazoles; Macrophages; Male; Oligopeptides; Radioimmunoassay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Signal Transduction; Sterol O-Acyltransferase; Tetrazoles; Up-Regulation; Vasoconstrictor Agents; Vasodilator Agents | 2008 |
The salted artery and angiotensin II signaling: a deadly duo in arterial disease.
Topics: Angiotensin II; Animals; Atherosclerosis; Mice; Muscle, Smooth, Vascular; Receptor, Angiotensin, Type 1; Signal Transduction; Sodium Chloride, Dietary | 2009 |
A CCR2/CCR5 antagonist attenuates an increase in angiotensin II-induced CD11b+ monocytes from atherogenic ApoE-/- mice.
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; CCR5 Receptor Antagonists; CD11b Antigen; Flow Cytometry; Gene Expression Regulation; Humans; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Rats; Receptors, CCR2 | 2009 |
[Effects of Xiongshao capsule on the proliferation of vascular smooth muscle cells in rabbits with atherosclerosis].
Topics: Angiotensin II; Animals; Atherosclerosis; Capsules; Cell Proliferation; Disease Models, Animal; Drugs, Chinese Herbal; Female; Humans; Male; Muscle, Smooth, Vascular; Proliferating Cell Nuclear Antigen; Rabbits | 2008 |
High-salt diet combined with elevated angiotensin II accelerates atherosclerosis in apolipoprotein E-deficient mice.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Apolipoproteins E; Atherosclerosis; Brachiocephalic Trunk; Female; Lipids; Mice; Oxidative Stress; Receptor, Angiotensin, Type 1; Sodium Chloride, Dietary | 2009 |
Downregulating osteopontin reduces angiotensin II-induced inflammatory activation in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Atherosclerosis; Down-Regulation; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Osteopontin; RNA, Small Interfering; Transcription Factor AP-1 | 2009 |
Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling.
Topics: Androgens; Angiotensin II; Animals; Aorta, Thoracic; Atherosclerosis; Coronary Vessels; Disease Models, Animal; Lipid Peroxidation; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Proto-Oncogene Proteins c-akt; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Androgen; Superoxides; Thiobarbituric Acid Reactive Substances; Transforming Growth Factor beta1; Vasoconstrictor Agents | 2009 |
ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Blood Pressure; Cholesterol, Dietary; Disease Models, Animal; Hydralazine; Hypercholesterolemia; Hypertension; Infusion Pumps, Implantable; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Norepinephrine; Receptors, LDL; Risk Factors; Time Factors | 2009 |
Cytomegalovirus infection causes an increase of arterial blood pressure.
Topics: Angiotensin II; Animals; Aorta; Atherosclerosis; Blood Pressure; Blood Vessels; Cell Line; Chi-Square Distribution; Cytokines; Cytomegalovirus Infections; Diet, Atherogenic; Disease Models, Animal; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Herpesviridae Infections; Humans; Mice; Mice, Inbred C57BL; Models, Biological; Muromegalovirus; Polymerase Chain Reaction; Renin; RNA, Viral; Virus Replication | 2009 |
Milk fat globule protein epidermal growth factor-8: a pivotal relay element within the angiotensin II and monocyte chemoattractant protein-1 signaling cascade mediating vascular smooth muscle cells invasion.
Topics: Adolescent; Adult; Aged; Aging; Angiotensin II; Animals; Antigens, Surface; Aorta; Atherosclerosis; Cell Movement; Chemokine CCL2; Gene Expression Regulation; Gene Silencing; Humans; Macaca mulatta; Male; Middle Aged; Milk Proteins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rats, Inbred F344; Receptors, CCR2; Signal Transduction; Vasoconstrictor Agents; Viral Proteins; Virulence Factors | 2009 |
Chymase activity is closely related with plaque vulnerability in a hamster model of atherosclerosis.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Apoptosis; Atherosclerosis; Body Weight; Cell Degranulation; Cholesterol; Chymases; Cricetinae; Disease Models, Animal; Disease Progression; Immunohistochemistry; Inflammation; Inflammation Mediators; Lipids; Male; Mast Cells; Mesocricetus; Microscopy, Electron, Transmission; ortho-Aminobenzoates; Ovalbumin; Peptidyl-Dipeptidase A; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rupture; Time Factors; Ultrasonography, Doppler, Duplex | 2009 |
Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Atherosclerosis; Chemokines; Cytokines; Mice; Mice, Knockout; Receptors, LDL; Receptors, Tumor Necrosis Factor, Type I; Signal Transduction | 2009 |
Predisposition to atherosclerosis and aortic aneurysms in mice deficient in kinin B1 receptor and apolipoprotein E.
Topics: Angiotensin II; Animals; Aortic Aneurysm; Apolipoproteins E; Atherosclerosis; Biomarkers; Cholesterol; Diet; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Bradykinin B1; RNA, Messenger | 2009 |
Bone marrow angiotensin AT1 receptor regulates differentiation of monocyte lineage progenitors from hematopoietic stem cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Cell Differentiation; Cell Lineage; Hematopoietic Stem Cells; Janus Kinase 2; Macrophage Colony-Stimulating Factor; Mice; Mice, Inbred C57BL; Monocytes; Phosphorylation; Protein Kinase C-delta; Receptor, Angiotensin, Type 1; Receptor, Macrophage Colony-Stimulating Factor; Receptors, LDL; Tumor Necrosis Factor-alpha | 2009 |
Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia.
Topics: Administration, Oral; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Biological Availability; Carotid Arteries; Cholesterol; Disease Models, Animal; Down-Regulation; Dyslipidemias; Enzyme Inhibitors; Epoxide Hydrolases; Inflammation Mediators; Intercellular Adhesion Molecule-1; Interleukin-1alpha; Interleukin-6; Interleukin-8; Ligation; Male; Mice; Mice, Knockout; Vascular Cell Adhesion Molecule-1 | 2009 |
Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Cell Proliferation; Cells, Cultured; ErbB Receptors; Heparin-binding EGF-like Growth Factor; Hepatocyte Growth Factor; Humans; Hyperplasia; Inflammation; Intercellular Signaling Peptides and Proteins; Ligands; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases; Phosphoric Monoester Hydrolases; Proteasome Endopeptidase Complex; Protein Processing, Post-Translational; Protein Transport; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Reactive Oxygen Species; Receptors, Growth Factor; RNA Interference; Signal Transduction; Superoxide Dismutase; Time Factors; Transfection; Ubiquitination | 2009 |
A role of matrix metalloproteinase-8 in atherosclerosis.
Topics: Angiotensin II; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Pressure; Carotid Artery Diseases; Collagen; Coronary Stenosis; Disease Models, Animal; Disease Progression; Endothelium, Vascular; Gene Frequency; Genetic Predisposition to Disease; Humans; Leukocyte Rolling; Macrophages; Male; Matrix Metalloproteinase 8; Mice; Mice, Knockout; Polymorphism, Single Nucleotide; Prospective Studies; Severity of Illness Index; Vascular Cell Adhesion Molecule-1 | 2009 |
Shear stress regulates angiotensin type 1 receptor expression in endothelial cells.
Topics: Angiotensin II; Animals; Atherosclerosis; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Down-Regulation; Endothelial Cells; Humans; Inflammation; Injections, Intravenous; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Protein Kinase Inhibitors; Pulsatile Flow; Receptor, Angiotensin, Type 1; Regional Blood Flow; RNA, Messenger; Signal Transduction; Stress, Mechanical; Time Factors; Vascular Cell Adhesion Molecule-1 | 2009 |
Evidence that nitric oxide inhibits vascular inflammation and superoxide production via a p47phox-dependent mechanism in mice.
Topics: Angiotensin II; Animals; Aorta; Atherosclerosis; Blood Pressure; Enzyme Inhibitors; Glycosylation; Hypertension; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; NADPH Oxidase 2; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Reactive Oxygen Species; Superoxides; Time Factors; Vascular Cell Adhesion Molecule-1; Vasculitis | 2010 |
Matrix metalloproteinase-8 and the regulation of blood pressure, vascular inflammation, and atherosclerotic lesion growth.
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Blood Pressure; Disease Models, Animal; Disease Progression; Humans; Inflammation; Matrix Metalloproteinase 8; Mice; Mice, Knockout; Vascular Cell Adhesion Molecule-1 | 2009 |
Angiotensin II up-regulates CX3CR1 expression in THP-1 monocytes: impact on vascular inflammation and atherogenesis.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; Cell Adhesion; Cell Movement; Chemokine CX3CL1; CX3C Chemokine Receptor 1; Endothelial Cells; Gene Expression Regulation; Humans; Inflammation; Jurkat Cells; Losartan; Monocytes; Receptors, CCR5; Receptors, Chemokine; Receptors, CXCR4; Vasculitis; Vasoconstrictor Agents | 2010 |
Influence of exercise and perivascular adipose tissue on coronary artery vasomotor function in a familial hypercholesterolemic porcine atherosclerosis model.
Topics: Adipose Tissue; Angiotensin II; Animals; Atherosclerosis; Bradykinin; Coronary Vessels; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin-1; Hyperlipoproteinemia Type II; Male; Nitroprusside; Physical Exertion; Sedentary Behavior; Swine; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2010 |
Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessment.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Contrast Media; Dextrans; Dietary Fats; Disease Models, Animal; Ferrosoferric Oxide; Humans; Immunohistochemistry; Infusion Pumps, Implantable; Macrophages; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Mice, Knockout; Mice, Transgenic; Naphthyridines; Peritonitis; Receptors, CCR2; Time Factors | 2010 |
Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.
Topics: Angiotensin II; Animals; Atherosclerosis; Cells, Cultured; Cohort Studies; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Humans; Hypertension; Interleukin-17; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Probability; Random Allocation; Reference Values; T-Lymphocytes; Vascular Diseases | 2010 |
Regulatory polymorphism in transcription factor KLF5 at the MEF2 element alters the response to angiotensin II and is associated with human hypertension.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Animals; Aorta; Atherosclerosis; Case-Control Studies; Cells, Cultured; Chromatin Immunoprecipitation; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hypertension; Immunoblotting; Immunoenzyme Techniques; Immunoprecipitation; Kruppel-Like Transcription Factors; MADS Domain Proteins; Male; MEF2 Transcription Factors; Middle Aged; Myogenic Regulatory Factors; p38 Mitogen-Activated Protein Kinases; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Rats; Reactive Oxygen Species; Response Elements; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Signal Transduction | 2010 |
Total lymphocyte deficiency attenuates AngII-induced atherosclerosis in males but not abdominal aortic aneurysms in apoE deficient mice.
Topics: Aneurysm; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; B-Lymphocytes; Female; Gene Expression Regulation; Genotype; Hypercholesterolemia; Lymphocytes; Male; Mice; T-Lymphocytes | 2010 |
Hypertension, obesity, and inflammation: the complex designs of a deadly trio.
Topics: Adaptive Immunity; Angiotensin II; Atherosclerosis; Genes, ras; Humans; Hypertension; Inflammation; Insulin Resistance; Metabolic Syndrome; Obesity; Oxidative Stress | 2010 |
Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.
Topics: Acetylcholine; Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelium, Vascular; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Pyridines; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Superoxides; Time Factors; Vasodilation; Vasodilator Agents | 2010 |
Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Cell Adhesion Molecules; Cell Proliferation; Cystatin C; Humans; Inflammation; Leukocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Smooth Muscle | 2010 |
Angiotensin II upregulates the expression of placental growth factor in human vascular endothelial cells and smooth muscle cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antibodies, Blocking; Atherosclerosis; Cell Proliferation; Cells, Cultured; Endothelium, Vascular; Humans; Mitogen-Activated Protein Kinase 3; Myocytes, Smooth Muscle; Phosphatidylinositol 3-Kinases; Placenta Growth Factor; Pregnancy Proteins; Protein Kinase C; Signal Transduction; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2010 |
Losartan inhibits LPS-induced inflammatory signaling through a PPARgamma-dependent mechanism in human THP-1 macrophages.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Atherosclerosis; Cell Line; Gene Expression; Humans; Hypertension; I-kappa B Proteins; Inflammation; Lipopolysaccharides; Losartan; Macrophages; Monocytes; Phosphorylation; PPAR gamma; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Signal Transduction | 2010 |
Olmesartan inhibits angiotensin II-Induced migration of vascular smooth muscle cells through Src and mitogen-activated protein kinase pathways.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Atherosclerosis; Cell Movement; Cells, Cultured; Dose-Response Relationship, Drug; Imidazoles; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Signal Transduction; src-Family Kinases; Tetrazoles | 2010 |
Angiotensin II induces C-reactive protein expression through ERK1/2 and JNK signaling in human aortic endothelial cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Aorta; Atherosclerosis; Blotting, Western; C-Reactive Protein; Cells, Cultured; Endothelial Cells; Humans; Inflammation; Interleukin-1beta; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Microscopy, Fluorescence; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; Phosphorylation; Protein Kinase Inhibitors; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors; Up-Regulation | 2010 |
The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Atherosclerosis; B-Cell CLL-Lymphoma 10 Protein; Blood Vessels; CARD Signaling Adaptor Proteins; Caspases; Endothelium, Vascular; Inflammation; Mice; Mice, Knockout; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein; Muscle, Smooth, Vascular; Neoplasm Proteins; NF-kappa B; Receptor, Angiotensin, Type 1; Signal Transduction | 2010 |
The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Atherosclerosis; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Enzyme Inhibitors; Humans; Imidazoles; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monocytes; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled; Tetrazoles | 2010 |
Pioglitazone-induced reductions in atherosclerosis occur via smooth muscle cell-specific interaction with PPAR{gamma}.
Topics: Angiotensin II; Animals; Aorta; Atherosclerosis; Cells, Cultured; Chemokine CCL2; Female; Hypoglycemic Agents; Male; Mice; Mice, Mutant Strains; Muscle, Smooth, Vascular; Pioglitazone; PPAR gamma; Receptors, LDL; Thiazolidinediones; Vasoconstrictor Agents | 2010 |
Immobilization stress induces endothelial dysfunction by oxidative stress via the activation of the angiotensin II/its type I receptor pathway.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Arteries; Atherosclerosis; Immobilization; Losartan; Male; Nitric Oxide Synthase Type III; Oxidative Stress; Ramipril; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin | 2010 |
To what extent does aortic pulse wave velocity estimate early atherosclerosis in Kurosawa and Kusanagi-hypercholesterolemic rabbits?
Topics: Angiotensin II; Animals; Aorta, Abdominal; Atherosclerosis; Blood Pressure; Hypercholesterolemia; Male; Nitroprusside; Pulsatile Flow; Rabbits; Ultrasonography; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents | 2011 |
Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Atherosclerosis; Bone Marrow Cells; Bone Marrow Transplantation; Cell Adhesion; Cells, Cultured; Coculture Techniques; Culture Media, Conditioned; Cytokines; Dietary Fats; Disease Models, Animal; Endothelial Cells; Humans; Inflammation Mediators; Losartan; Macrophages; Male; Mice; Mice, Knockout; Monocytes; Peptide Fragments; Peptidyl-Dipeptidase A; Receptors, LDL | 2011 |
Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro.
Topics: Angiotensin II; Animals; Aortic Diseases; Atherosclerosis; Blotting, Western; Cardiovascular Agents; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Hypercholesterolemia; Immunohistochemistry; Lipids; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Radioimmunoassay; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Time Factors | 2011 |
Th17 response promotes angiotensin II-induced atherosclerosis.
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Humans; Interleukin-18; Mice; Mice, Mutant Strains; Th17 Cells | 2011 |
Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration.
Topics: Angiotensin II; Atherosclerosis; Cell Adhesion; Cell Movement; Endothelium, Vascular; Humans; Inflammation; Jurkat Cells; MicroRNAs; Proto-Oncogene Protein c-ets-1; Receptor, Angiotensin, Type 1 | 2011 |
Pivotal role of protein kinase Cdelta in angiotensin II-induced endothelial cyclooxygenase-2 expression: a link to vascular inflammation.
Topics: Aged; Aged, 80 and over; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Blotting, Western; Cells, Cultured; Chemokine CCL2; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Humans; Hypertension; Inflammation; Inflammation Mediators; Male; Mesenteric Arteries; Middle Aged; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C-delta; Protein Kinase Inhibitors; Protein Transport; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; RNA Interference; Signal Transduction; Time Factors; Tissue Culture Techniques; Up-Regulation | 2011 |
Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Apolipoproteins E; Atherosclerosis; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Hydrogen Peroxide; Infusion Pumps, Implantable; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Peptide Fragments; Perfusion; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Vasodilation | 2011 |
Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice.
Topics: Aged; Angiotensin II; Animals; Antibodies, Neutralizing; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Cells, Cultured; Dendritic Cells; Dietary Fats; Disease Models, Animal; Female; Humans; Inflammation; Interferon-gamma; Interleukin-17; Ligation; Lymphocytes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Nitric Oxide; Spleen; Superoxides; Time Factors | 2011 |
Statins exert differential effects on angiotensin II-induced atherosclerosis, but no benefit for abdominal aortic aneurysms.
Topics: Angiotensin II; Animal Feed; Animals; Anti-Inflammatory Agents; Aorta; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Atorvastatin; Blood Pressure; Fluorobenzenes; Gene Expression Regulation; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Mice; Mice, Inbred C57BL; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides | 2011 |
Molecular mechanism of vasorelaxant and antiatherogenic effects of the statins in the human saphenous vein graft.
Topics: Angiotensin II; Atherosclerosis; Coronary Artery Bypass; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Prostaglandin-Endoperoxide Synthases; rho-Associated Kinases; Saphenous Vein; Vasodilation; Vasodilator Agents | 2011 |
Differential roles of endothelin-1 in angiotensin II-induced atherosclerosis and aortic aneurysms in apolipoprotein E-null mice.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Aortic Aneurysm; Apolipoproteins E; Atherosclerosis; Biomechanical Phenomena; Bosentan; Cardiovascular Agents; Cell Adhesion; Collagen; Down-Regulation; Endothelin-1; Integrin beta1; Interferon-gamma; Mice; Mice, Knockout; Stress, Physiological; Sulfonamides; Vasoconstrictor Agents | 2011 |
Nuclear factor of activated T cells 5 regulates vascular smooth muscle cell phenotypic modulation.
Topics: Actins; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Becaplermin; Binding Sites; Carotid Artery Injuries; Cell Movement; Cell Proliferation; Cells, Cultured; Chromatin Immunoprecipitation; Coculture Techniques; Computational Biology; Disease Models, Animal; Gene Expression Regulation; Genes, Reporter; Humans; Hyperplasia; Introns; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NFATC Transcription Factors; Phenotype; Platelet-Derived Growth Factor; Promoter Regions, Genetic; Protein Transport; Proto-Oncogene Proteins c-sis; Rats; RNA Interference; RNA, Messenger; Transcription Factors; Transfection; Tunica Intima | 2011 |
Chinese red yeast rice attenuates the development of angiotensin II-induced abdominal aortic aneurysm and atherosclerosis.
Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Biological Products; Chemokine CCL2; Cholesterol; Inflammation; Interleukin-1alpha; Interleukin-6; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Plant Extracts; Tunica Intima | 2012 |
Polychlorinated biphenyl 77 augments angiotensin II-induced atherosclerosis and abdominal aortic aneurysms in male apolipoprotein E deficient mice.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Blood Pressure; Drug Synergism; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Polychlorinated Biphenyls; Real-Time Polymerase Chain Reaction | 2011 |
MyD88 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation independent of signaling through Toll-like receptors 2 and 4.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Leukocytes; Male; Mice; Mice, Knockout; Myeloid Differentiation Factor 88; Receptors, LDL; Signal Transduction; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2011 |
Calpain inhibition attenuates angiotensin II-induced abdominal aortic aneurysms and atherosclerosis in low-density lipoprotein receptor-deficient mice.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Atherosclerosis; Blotting, Western; Calpain; Cysteine Proteinase Inhibitors; Diet, High-Fat; Disease Models, Animal; Hypercholesterolemia; Male; Mice; Mice, Knockout; Receptors, LDL; Sulfonamides | 2012 |
Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Apolipoproteins E; Apoptosis; Atherosclerosis; Cell Polarity; Disease Models, Animal; Female; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Nephrectomy; Phenotype; Receptor, Angiotensin, Type 1 | 2011 |
Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis.
Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Atherosclerosis; Blood Pressure; Cholesterol; Diet, High-Fat; Enalapril; Fumarates; Hypercholesterolemia; Kidney; Losartan; Male; Mice; Mice, Knockout; Receptor, Angiotensin, Type 1; Receptors, LDL; Renin; Renin-Angiotensin System | 2012 |
Deficiency of receptor-associated protein attenuates angiotensin II-induced atherosclerosis in hypercholesterolemic mice without influencing abdominal aortic aneurysms.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Atherosclerosis; Bone Marrow Cells; Bone Marrow Transplantation; Cells, Cultured; Cholesterol; Disease Models, Animal; Hypercholesterolemia; LDL-Receptor Related Protein-Associated Protein; Low Density Lipoprotein Receptor-Related Protein-1; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Receptors, LDL; Tumor Suppressor Proteins | 2012 |
Endothelial-specific Nox2 overexpression increases vascular superoxide and macrophage recruitment in ApoE⁻/⁻ mice.
Topics: Angiotensin II; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Pressure; Chemotaxis; Disease Models, Animal; Disease Progression; Endothelial Cells; Humans; Macrophages; Membrane Glycoproteins; Mice; Mice, Knockout; Mice, Transgenic; NADPH Oxidase 2; NADPH Oxidases; Signal Transduction; Superoxides; Time Factors; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 2012 |
A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Aneurysm, Abdominal; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Chemotaxis, Leukocyte; Disease Models, Animal; Dose-Response Relationship, Drug; Lymphocyte Activation; Macrophage Activation; Male; Mice; Mice, Knockout; Peptides; Platelet Endothelial Cell Adhesion Molecule-1; Receptors, Antigen, T-Cell; T-Lymphocytes; Time Factors | 2012 |
CD31: beyond a marker for endothelial cells.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aortic Aneurysm, Abdominal; Aortic Diseases; Atherosclerosis; Male; Peptides; Platelet Endothelial Cell Adhesion Molecule-1 | 2012 |
Distinct MAPK pathways are involved in IL-23 production in dendritic cells cocultured with NK cells in the absence or presence of angiotensin II.
Topics: Angiotensin II; Animals; Atherosclerosis; Bone Marrow Cells; Cell Communication; Cells, Cultured; Coculture Techniques; Dendritic Cells; Extracellular Signal-Regulated MAP Kinases; Female; Interleukin-23; JNK Mitogen-Activated Protein Kinases; Killer Cells, Natural; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases | 2012 |
Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Atherosclerosis; Carotid Artery Diseases; Carotid Artery, Common; CD36 Antigens; Disease Models, Animal; Disease Progression; Focal Adhesion Kinase 1; Gene Deletion; JNK Mitogen-Activated Protein Kinases; Lipids; Lipoproteins, LDL; Macrophages; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Plaque, Atherosclerotic; Receptor, Angiotensin, Type 1; Rupture, Spontaneous; Superoxides; Tetrazoles; Time Factors; Valine; Valsartan | 2012 |
Transient exposure of neonatal female mice to testosterone abrogates the sexual dimorphism of abdominal aortic aneurysms.
Topics: Age Factors; Angiotensin II; Animals; Animals, Newborn; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Female; Hydrogen Peroxide; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Receptor, Angiotensin, Type 1; Receptors, LDL; Risk Factors; RNA, Messenger; Sex Characteristics; Sex Factors; Testosterone Propionate; Up-Regulation | 2012 |
Prostaglandin receptor EP4 in abdominal aortic aneurysms.
Topics: Adult; Angiotensin II; Animals; Aorta; Aortic Aneurysm, Abdominal; Aortic Rupture; Atherosclerosis; Cyclooxygenase 2; Drug Evaluation, Preclinical; Female; Gene Knockdown Techniques; Humans; Macrophages; Male; Mice; Mice, Knockout; Middle Aged; Naphthalenes; Phenylbutyrates; Receptors, Prostaglandin E, EP4 Subtype; Signal Transduction; Ultrasonography | 2012 |
Endothelial Gab1 deletion accelerates angiotensin II-dependent vascular inflammation and atherosclerosis in apolipoprotein E knockout mice.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Down-Regulation; Female; Gene Deletion; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Male; Mice; Mice, Knockout; Phosphoproteins; Vasculitis | 2012 |
The versatile role of Gab1 in the circulatory system.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Female; Gene Deletion; Male; Phosphoproteins; Vasculitis | 2012 |
Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD(P)H oxidase and COX-1.
Topics: Angiotensin II; Animals; Atherosclerosis; Cyclooxygenase 1; Disease Models, Animal; Endothelium, Vascular; Enzyme Induction; Enzyme Inhibitors; Extracellular Matrix; Fibrosis; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mechanical Phenomena; Membrane Proteins; Mesenteric Arteries; NADPH Oxidase 4; NADPH Oxidases; Phosphorylation; Protein Processing, Post-Translational; Pyrimidines; Rats; Rats, Sprague-Dawley; Rosuvastatin Calcium; Sulfonamides; Vascular Resistance; Vasodilation | 2013 |
The role of lysyl oxidase family members in the stabilization of abdominal aortic aneurysms.
Topics: Amino Acid Oxidoreductases; Aminopropionitrile; Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Diet, High-Fat; Disease Models, Animal; Extracellular Matrix; Extracellular Matrix Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Protein-Lysine 6-Oxidase; RNA, Messenger; Vasoconstrictor Agents | 2012 |
Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Arteries; Arterioles; Atherosclerosis; Cell Adhesion; Cells, Cultured; Chemokine CX3CL1; CX3C Chemokine Receptor 1; Disease Models, Animal; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Female; Human Umbilical Vein Endothelial Cells; Humans; Interferon-gamma; Leukocyte Rolling; Leukocytes; Losartan; Male; Membrane Glycoproteins; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidase 5; NADPH Oxidases; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Receptors, Chemokine; RNA Interference; Signal Transduction; Time Factors; Transfection; Tumor Necrosis Factor-alpha; Veins; Venules | 2013 |
Regional variation in aortic AT1b receptor mRNA abundance is associated with contractility but unrelated to atherosclerosis and aortic aneurysms.
Topics: Angiotensin II; Animals; Aorta; Aortic Aneurysm; Arterial Pressure; Atherosclerosis; Gene Expression Regulation; Male; Mice; Mice, Knockout; Muscle Contraction; Receptor, Angiotensin, Type 1; RNA, Messenger; Transcription, Genetic | 2012 |
Angiotensin II induces TSLP via an AT1 receptor/NF-KappaB pathway, promoting Th17 differentiation.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Atherosclerosis; Cell Differentiation; Cells, Cultured; Cytokines; Dendritic Cells; Gene Expression; Hypertension; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Th17 Cells; Thymic Stromal Lymphopoietin; Transcriptional Activation; Tumor Necrosis Factor-alpha | 2012 |
Angiotensin II promotes aortic valve thickening independent of elevated blood pressure in apolipoprotein-E deficient mice.
Topics: Angiotensin II; Animals; Aortic Valve; Aortic Valve Stenosis; Apolipoproteins E; Atherosclerosis; Hypertension; Male; Mice; Mice, Inbred C57BL | 2013 |
Biomechanical modeling and morphology analysis indicates plaque rupture due to mechanical failure unlikely in atherosclerosis-prone mice.
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Biomechanical Phenomena; Calcinosis; Computer Simulation; Dietary Fats; Humans; Image Processing, Computer-Assisted; Mice; Mice, Knockout; Models, Biological; Phenotype; Plaque, Atherosclerotic; Receptors, LDL; Stress, Mechanical | 2013 |
Angiotensin-(1-7) regulates Angiotensin II-induced VCAM-1 expression on vascular endothelial cells.
Topics: Angiotensin I; Angiotensin II; Atherosclerosis; Cell Line; Endothelium, Vascular; Humans; NF-kappa B; Peptide Fragments; Protein Transport; Receptors, G-Protein-Coupled; Vascular Cell Adhesion Molecule-1 | 2013 |
Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Apolipoproteins E; Atherosclerosis; Chemokine CCL2; Disease Models, Animal; Female; Follow-Up Studies; Hyperlipidemias; Immunohistochemistry; Infusions, Intravenous; Mice; Mice, Inbred C57BL; Receptors, CCR2; Receptors, Chemokine; RNA | 2006 |
Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Gene Deletion; Imidazoles; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Oxidative Stress; Phosphoproteins; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridines; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Tetrazoles; Valine; Valsartan | 2005 |
Angiotensin II infusion induces site-specific intra-laminar hemorrhage in macrophage colony-stimulating factor-deficient mice.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Atherosclerosis; Cell Movement; Female; Frameshift Mutation; Hematoma; Hemorrhage; Infusion Pumps, Implantable; Macrophage Colony-Stimulating Factor; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Osteopetrosis | 2006 |
Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis.
Topics: Angiotensin II; Atherosclerosis; Binding Sites; Endothelial Cells; Gene Expression Regulation; Humans; Lipoproteins, LDL; Mutation; Octamer Transcription Factor-1; Promoter Regions, Genetic; Scavenger Receptors, Class E; Transcription, Genetic | 2006 |
Transcriptional repression of ATP-binding cassette transporter A1 gene in macrophages: a novel atherosclerotic effect of angiotensin II.
Topics: Angiotensin II; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Cholesterol; Fos-Related Antigen-2; Macrophages; Mice; Promoter Regions, Genetic; Receptors, LDL; Repressor Proteins; RNA, Messenger; RNA, Small Interfering; Transcription, Genetic | 2005 |
Angiotensin II as a multifunctional hormone: a regulator of haemodynamics and metabolism with potential roles in the etiologies of hypertension and the metabolic syndrome.
Topics: Angiotensin II; Animals; Atherosclerosis; Blood Glucose; Cholesterol; Hemodynamics; Hypertension; Metabolic Syndrome; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2006 |
Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Atherosclerosis; Blood Pressure; Chemokine CCL2; Dose-Response Relationship, Drug; Endothelium, Vascular; Hypertension; Hypertrophy, Left Ventricular; In Vitro Techniques; Membrane Glycoproteins; Mice; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidases; Osmolar Concentration; Rats; Rats, Inbred Dahl; Renin; RNA, Messenger; Scavenger Receptors, Class E; Sodium Chloride, Dietary; Systole; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2006 |
Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress.
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Blood Flow Velocity; C-Reactive Protein; Carotid Arteries; Carotid Stenosis; Diet, Atherogenic; Hemorheology; Hemorrhage; Hyperlipoproteinemia Type II; Hyperplasia; Intercellular Adhesion Molecule-1; Interleukin-6; Lipids; Macrophages; Male; Mice; Mice, Inbred C57BL; Phenotype; Prostheses and Implants; Shear Strength; Stress, Mechanical; Tunica Intima; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A | 2006 |
Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Blood Pressure; Cholesterol; Gene Deletion; Gene Expression Regulation; Macrophages; Male; Matrix Metalloproteinase 2; Mice; Mice, Knockout; NADPH Oxidases; Oxidative Stress; Phenylephrine; Superoxides; Triglycerides | 2006 |
Angiotensin II induces histomorphologic features of unstable plaque in a murine model of accelerated atherosclerosis.
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Chemokine CCL2; Disease Models, Animal; Foam Cells; Immunohistochemistry; Ligation; Male; Matrix Metalloproteinase 2; Mice; Mice, Knockout; Tunica Intima; Vascular Cell Adhesion Molecule-1 | 2006 |
Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway.
Topics: Aging, Premature; Angiotensin II; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Blood Pressure; Cells, Cultured; Disease Models, Animal; Genes, Reporter; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Transfection | 2006 |
Mechanics or mediators: arterial damage from high blood pressure.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Humans; Hypertension; Mice | 2006 |
Role of integrin-linked kinase in vascular smooth muscle cells: regulation by statins and angiotensin II.
Topics: Angiotensin II; Animals; Atherosclerosis; Cell Movement; Cell Proliferation; Cells, Cultured; Male; Mice; Muscle, Smooth, Vascular; Protein Serine-Threonine Kinases; Rats | 2006 |
Angiotensin II increases expression and secretion of cathepsin F in cultured human monocyte-derived macrophages: an angiotensin II type 2 receptor-mediated effect.
Topics: Angiotensin II; Atherosclerosis; Cathepsin F; Cathepsins; Cell Survival; Humans; Imidazoles; Losartan; Macrophages; Pyridines; Receptor, Angiotensin, Type 2 | 2007 |
Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation.
Topics: Adiponectin; Adipose Tissue; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Cells, Cultured; Female; Gene Expression Regulation; Imidazoles; Kidney Diseases; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Oxidative Stress; Plasminogen Activator Inhibitor 1; Reactive Oxygen Species; RNA, Messenger; Serum Amyloid A Protein; Signal Transduction; Tetrazoles; Tumor Necrosis Factor-alpha | 2006 |
Angiotensin II-induced C-reactive protein generation: inflammatory role of vascular smooth muscle cells in atherosclerosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; C-Reactive Protein; Cells, Cultured; Losartan; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Receptor Cross-Talk | 2007 |
ACE inhibitors and aortic rupture.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Aneurysm; Atherosclerosis; Humans; Losartan; Mice | 2006 |
Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice.
Topics: Angiotensin II; Animals; Aorta; Atherosclerosis; Fibroblasts; Interleukin-6; Janus Kinases; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Organ Culture Techniques; Phosphorylation; Receptors, LDL; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; Tyrosine; Vasoconstrictor Agents | 2007 |
Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms.
Topics: Aneurysm; Angiotensin II; Animals; Atherosclerosis; Bone Marrow Cells; Bone Marrow Transplantation; Diet, Atherogenic; Dietary Fats; Gene Expression Regulation; Infusion Pumps; Male; Mice; Mice, Transgenic; Receptor, Angiotensin, Type 1; Receptors, LDL; Transplantation Chimera | 2007 |
Endogenous angiotensin II enhances atherogenesis in apoprotein E-deficient mice with renovascular hypertension through activation of vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Biomarkers; Cell Line; Culture Media, Conditioned; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorescent Antibody Technique, Indirect; Foam Cells; Gene Silencing; Hypertension, Renovascular; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Sinus of Valsalva | 2007 |
Forkhead transcription factor FOXO3a is a negative regulator of angiogenic immediate early gene CYR61, leading to inhibition of vascular smooth muscle cell proliferation and neointimal hyperplasia.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Apoptosis; Atherosclerosis; Carotid Artery Injuries; Catheterization; Cell Division; Cells, Cultured; Culture Media; Culture Media, Conditioned; Cysteine-Rich Protein 61; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation; Genes, Reporter; Humans; Hyperplasia; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; Mice; Muscle, Smooth, Vascular; Oligonucleotides, Antisense; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Transcription, Genetic; Transduction, Genetic; Tunica Intima | 2007 |
PTEN reduces cuff-induced neointima formation and proinflammatory cytokines.
Topics: Adenoviridae; Angiotensin II; Animals; Apoptosis; Atherosclerosis; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Cytokines; Disease Models, Animal; Femoral Artery; Genetic Therapy; Genetic Vectors; I-kappa B Proteins; Inflammation; Interleukin-1beta; Macrophages; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-KappaB Inhibitor alpha; Phosphorylation; PTEN Phosphohydrolase; Rats; Rats, Wistar; RNA, Messenger; Transfection; Tumor Necrosis Factor-alpha; Tunica Intima | 2007 |
Foxing smooth muscle cells: FOXO3a-CYR61 connection.
Topics: Angiotensin II; Animals; Apoptosis; Arteries; Atherosclerosis; Cell Division; Cells, Cultured; Culture Media, Conditioned; Cysteine-Rich Protein 61; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation; Humans; Hyperplasia; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Mice; Muscle Cells; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Rats; Recombinant Fusion Proteins; Transcription, Genetic; Tunica Intima | 2007 |
Angiotensin II promotes the inflammatory response to CD40 ligation via TRAF-2.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; CD40 Antigens; CD40 Ligand; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Inflammation; Interleukin-6; Losartan; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Receptor Cross-Talk; Receptor, Angiotensin, Type 1; Saphenous Vein; TNF Receptor-Associated Factor 2; Up-Regulation | 2007 |
Interferon-beta attenuates angiotensin II-accelerated atherosclerosis and vascular remodeling in apolipoprotein E deficient mice.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Carotid Artery, Common; Cell Division; Drug Interactions; Foam Cells; Immunologic Factors; Interferon-beta; Ligation; Male; Mice; Mice, Mutant Strains; Tunica Intima; Vasoconstrictor Agents | 2008 |
Tetramethylpyrazine inhibits agiontensin II-induced nuclear factor-kappaB activation and bone morphogenetic protein-2 downregulation in rat vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Atherosclerosis; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Immunohistochemistry; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Pyrazines; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2007 |
Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage.
Topics: Albuminuria; Angiotensin II; Animals; Atherosclerosis; Cells, Cultured; Endothelial Cells; Gene Expression Regulation; Humans; Hypertension; I-kappa B Proteins; Inflammation; Intercellular Adhesion Molecule-1; Kidney Diseases; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Cardiovascular; Nephritis; NF-kappa B; NF-KappaB Inhibitor alpha; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Organ Specificity; Receptor, TIE-1; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sodium Chloride, Dietary; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2007 |
Angiotensin inhibition decreases progression of advanced atherosclerosis and stabilizes established atherosclerotic plaques.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Pressure; Body Weight; Disease Progression; Elasticity; Female; Hydralazine; Lipids; Losartan; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Vasoconstrictor Agents | 2007 |
Endothelial NF-kappaB as a mediator of kidney damage: the missing link between systemic vascular and renal disease?
Topics: Albuminuria; Angiotensin II; Animals; Atherosclerosis; Endothelium, Vascular; Fibrosis; Gemfibrozil; Humans; Hypertension; I-kappa B Proteins; Inflammation; Kidney Diseases; Mice; Models, Cardiovascular; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type III; Organ Specificity; Sodium Chloride, Dietary | 2007 |
Clinical pathology and treatment of renin-angiotensin system 3. Atherosclerosis and the renin-angiotensin system.
Topics: Angiotensin II; Animals; Atherosclerosis; Coronary Artery Disease; Endothelium, Vascular; Mice; Oxidative Stress; Receptors, Angiotensin; Renin-Angiotensin System | 2007 |
CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Cell Adhesion; Cells, Cultured; Chemokine CCL2; Chemokine CCL3; Chemokine CCL4; Chemokine CCL5; Chemokine CCL7; Chemotaxis, Leukocyte; Endothelial Cells; Humans; Inflammation; Leukocytes, Mononuclear; Losartan; Macrophage Inflammatory Proteins; Male; Microcirculation; Monocyte Chemoattractant Proteins; Neutrophil Infiltration; Rats; Rats, Sprague-Dawley; Receptors, Interleukin-8B; Splanchnic Circulation | 2007 |
Absence of peroxisome proliferator-activated receptor-alpha abolishes hypertension and attenuates atherosclerosis in the Tsukuba hypertensive mouse.
Topics: Aldosterone; Angiotensin II; Animals; Atherosclerosis; Blood Pressure; Cardiomegaly; Diet, Atherogenic; Disease Models, Animal; Fenofibrate; Genotype; Humans; Hypertension; Hypolipidemic Agents; Mice; Mice, Knockout; Mice, Transgenic; PPAR alpha; Renin; Renin-Angiotensin System | 2007 |
Critical role of bone marrow angiotensin II type 1 receptor in the pathogenesis of atherosclerosis in apolipoprotein E deficient mice.
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Bone Marrow Transplantation; Disease Models, Animal; Male; Mice; Mice, Knockout; Receptor, Angiotensin, Type 1; Transplantation Chimera | 2008 |
Overexpression of PAI-1 prevents the development of abdominal aortic aneurysm in mice.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Cytomegalovirus; Fibrosis; Gene Expression; Genetic Therapy; Genetic Vectors; Luciferases; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Plasminogen Activator Inhibitor 1; Transduction, Genetic; Urokinase-Type Plasminogen Activator | 2008 |
Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development.
Topics: Angiotensin II; Animals; Apolipoproteins B; Atherosclerosis; Blood Vessels; Carotid Arteries; Lipoproteins, LDL; Mice; Mice, Knockout; Norepinephrine; Proteoglycans; Receptors, LDL | 2008 |
Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice.
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Female; Hypercholesterolemia; Interleukin-4; Male; Mice; Mice, Mutant Strains; Receptors, LDL | 2007 |
Decoupled syndecan 1 mRNA and protein expression is differentially regulated by angiotensin II in macrophages.
Topics: Angiotensin II; Animals; Aorta; Atherosclerosis; Bucladesine; Cells, Cultured; Dose-Response Relationship, Drug; Gene Expression Regulation; Macrophages; Male; Mice; Mice, Inbred C57BL; RNA, Messenger; Signal Transduction; Syndecan-1; Time Factors; Up-Regulation | 2008 |
Angiotensin II: one driving force behind atherogenesis.
Topics: Angiotensin II; Animals; Atherosclerosis; Desoxycorticosterone; Humans; Hypertension; Sodium Chloride | 2008 |
Deoxycorticosterone acetate salt hypertension in apolipoprotein E-/- mice results in accelerated atherosclerosis: the role of angiotensin II.
Topics: Angiotensin II; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Blood Vessels; Desoxycorticosterone; Hypertension; Mice; Mice, Knockout; Renin-Angiotensin System; Sodium Chloride; Time Factors | 2008 |
p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment.
Topics: Angiotensin II; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Contrast Media; Enzyme Inhibitors; Feasibility Studies; Ferrosoferric Oxide; Imidazoles; Inflammation; Magnetic Resonance Angiography; Male; Metal Nanoparticles; Mice; Mice, Knockout; p38 Mitogen-Activated Protein Kinases; Pyrimidines; Vasoconstrictor Agents | 2008 |
Regional heterogeneity of functional changes in conduit arteries after high-fat diet.
Topics: Acetylcholine; Angiotensin II; Animals; Atherosclerosis; Carotid Arteries; Dietary Fats; Endothelin-1; Femoral Artery; Hydroxyl Radical; Male; Mice; Mice, Inbred C57BL; Obesity; Reactive Oxygen Species; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2008 |
Coupling factor 6 downregulates platelet endothelial cell adhesion molecule-1 via c-Src activation and acts as a proatherogenic molecule.
Topics: Angiotensin II; Aorta; Atherosclerosis; Cells, Cultured; CSK Tyrosine-Protein Kinase; Down-Regulation; Endothelial Cells; Humans; Mitochondrial Proton-Translocating ATPases; Nitric Oxide; Oxidative Phosphorylation Coupling Factors; Phosphorylation; Platelet Endothelial Cell Adhesion Molecule-1; Protein-Tyrosine Kinases; src-Family Kinases; Umbilical Veins | 2008 |
The effect of social environment on markers of vascular oxidative stress and inflammation in the Watanabe heritable hyperlipidemic rabbit.
Topics: Agonistic Behavior; Angiotensin II; Animals; Aorta, Thoracic; Arousal; Atherosclerosis; C-Reactive Protein; Cholesterol; Epinephrine; Hyperlipidemias; Inflammation Mediators; Lipoproteins, HDL; Lipoproteins, LDL; Male; NADPH Oxidases; Norepinephrine; Oxidative Stress; Peptidyl-Dipeptidase A; Rabbits; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Social Environment; Social Isolation; Stress, Psychological | 2008 |
Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Atherosclerosis; Cells, Cultured; Cholesterol Esters; Disease Models, Animal; Humans; Hypertension; Imidazoles; Lactoferrin; Losartan; Low Density Lipoprotein Receptor-Related Protein-1; Male; Muscle, Smooth, Vascular; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA Interference; RNA, Messenger; RNA, Small Interfering; Time Factors; Up-Regulation | 2008 |
Angiotensin IV-evoked vasoprotection is conserved in advanced atheroma.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atherosclerosis; Blood Pressure; Diet, Atherogenic; Disease Models, Animal; Endothelial Cells; Imidazoles; Male; Mice; Mice, Knockout; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pyridines; Receptors, Angiotensin; Superoxides; Up-Regulation | 2008 |
PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis.
Topics: Adipokines; Angiotensin II; Animals; Atherosclerosis; Cell Movement; Enzyme Activation; Gene Expression Regulation; Hypercholesterolemia; Hypertriglyceridemia; Inflammation; Ligands; Macrophages; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; PPAR delta; Proto-Oncogene Proteins c-bcl-6; Receptors, LDL; Signal Transduction; Thiazoles; Transcription, Genetic | 2008 |
Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis.
Topics: Adenoviridae; Angioplasty, Balloon; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Aorta, Abdominal; Atherosclerosis; Cell Line; Cells, Cultured; Collagen; Diet, Atherogenic; Dietary Fats; Disease Models, Animal; Disease Progression; Genetic Vectors; Humans; Mice; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rabbits; Receptors, G-Protein-Coupled; Time Factors; Transduction, Genetic; Up-Regulation | 2008 |
Liver X receptor activator downregulates angiotensin II type 1 receptor expression through dephosphorylation of Sp1.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Atherosclerosis; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p16; DNA-Binding Proteins; Down-Regulation; Gene Expression Regulation; Histone Deacetylases; Hydrocarbons, Fluorinated; Liver X Receptors; Muscle, Smooth, Vascular; Mutagenesis; Orphan Nuclear Receptors; Phosphorylation; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Sp1 Transcription Factor; Sulfonamides; Transcription, Genetic; Vasoconstrictor Agents | 2008 |
Androgen increases AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E-deficient mice.
Topics: Androgens; Angiotensin II; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Dihydrotestosterone; Disease Models, Animal; Drug Implants; Female; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Orchiectomy; Ovariectomy; Receptor, Angiotensin, Type 1; RNA, Messenger; Sex Factors; Time Factors; Up-Regulation | 2008 |